0001022652-21-000017 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover - USD ($) $ in Millions	12 Months Ended
Cover - USD ($) $ in Millions	Dec. 31, 2020	Feb. 23, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2020
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-38358
Entity Registrant Name	INSEEGO CORP.
Entity Central Index Key	0001022652
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-3377646
Entity Address, Address Line One	12600 Deerfield Parkway, Suite 100
Entity Address, City or Town	Alpharetta,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30004
City Area Code	858
Local Phone Number	812-3400
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	INSG
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 792.0
Entity Common Stock, Shares Outstanding		101,932,128
Documents Incorporated by Reference	Portions of the registrant’s definitive proxy statement for the 2021 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A are incorporated by reference into Part III of this Form 10-K to the extent stated herein.

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 40,015	$ 12,074
Accounts receivable, net of allowance for doubtful accounts of $1,384 and $2,133, respectively	29,940	19,656
Inventories	33,952	25,290
Prepaid expenses and other	10,201	7,117
Total current assets	114,108	64,137
Property, plant and equipment, net	13,699	10,756
Rental assets, net	6,109	5,385
Intangible assets, net	51,487	44,392
Goodwill	32,511	33,659
Right-of-use assets, net	9,092	2,657
Other assets	388	387
Total assets	227,394	161,373
Current liabilities:
Accounts payable	52,339	26,482
Accrued expenses and other current liabilities	23,373	18,048
Total current liabilities	75,712	44,530
Long-term liabilities:
Term loan, net	0	46,538
Deferred tax liabilities, net	4,505	3,949
Other long-term liabilities	9,929	2,380
Total liabilities	255,293	198,731
Commitments and Contingencies
Stockholders’ deficit:
Series E Preferred stock, par value $0.001; 39,500 and 10,000 shares designated, respectively, 35,000 and 10,000 shares issued and outstanding, respectively, liquidation preference of $1,000 per share (plus any accrued but unpaid dividends)	0	0
Common stock, par value $0.001; 150,000,000 shares authorized,99,399,029 and 81,974,051 shares issued and outstanding, respectively	99	82
Additional paid-in capital	711,487	584,862
Accumulated other comprehensive loss	(6,972)	(3,879)
Accumulated deficit	(732,422)	(618,303)
Total stockholders’ deficit attributable to Inseego Corp.	(27,808)	(37,238)
Noncontrolling interests	(91)	(120)
Total stockholders’ deficit	(27,899)	(37,358)
Total liabilities and stockholders’ deficit	227,394	161,373
2025 Notes
Long-term liabilities:
Convertible senior notes, net	165,147	0
2022 Notes
Long-term liabilities:
Convertible senior notes, net	$ 0	$ 101,334

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Allowance for doubtful accounts receivable	$ 1,384	$ 2,133
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000	2,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	99,399,029	81,974,051
Common stock, shares outstanding	99,399,029	81,974,051
Series E preferred shares
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	39,500	10,000
Preferred stock, shares issued	35,000	10,000
Preferred stock, shares outstanding	35,000	10,000
Preferred stock, liquidation preference per share (in dollars per share)	$ 1,000	$ 1,000

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Net revenues:
IoT & Mobile Solutions	$ 261,169,000	$ 160,873,000
Enterprise SaaS Solutions	52,663,000	58,623,000
Total net revenues	313,832,000	219,496,000
Cost of net revenues:
IoT & Mobile Solutions	202,421,000	132,980,000
Enterprise SaaS Solutions	20,568,000	22,545,000
Total cost of net revenues	222,989,000	155,525,000
Gross profit	90,843,000	63,971,000
Operating costs and expenses:
Research and development	44,953,000	23,853,000
Sales and marketing	35,750,000	28,914,000
General and administrative	30,689,000	27,327,000
Amortization of purchased intangible assets	3,175,000	3,421,000
Impairment of capitalized software	1,410,000	0
Total operating costs and expenses	115,977,000	83,515,000
Operating loss	(25,134,000)	(19,544,000)
Other income (expense):
Loss on debt conversion and extinguishment, net	(76,354,000)	0
Interest expense, net	(9,942,000)	(20,381,000)
Other income, net	992,000	351,000
Loss before income taxes	(110,438,000)	(39,574,000)
Income tax provision	748,000	536,000
Net loss	(111,186,000)	(40,110,000)
Less: Net income attributable to noncontrolling interests	(29,000)	(15,000)
Net loss attributable to Inseego Corp.	(111,215,000)	(40,125,000)
Series E preferred stock dividends	(2,904,000)	(361,000)
Net loss attributable to common stockholders	$ (114,119,000)	$ (40,486,000)
Net loss per common share:
Net loss per share, basic and diluted (in dollars per share)	$ (1.19)	$ (0.52)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding, basic and diluted (in shares)	96,111,547	78,322,496

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (111,186)	$ (40,110)
Foreign currency translation adjustment	(3,093)	998
Total comprehensive loss	(114,279)	(39,112)
Comprehensive income attributable to noncontrolling interests	(29)	(15)
Comprehensive loss attributable to Inseego Corp.	$ (114,308)	$ (39,127)

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686

+ Details

Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	2022 Notes	2025 Notes	Series E preferred shares	Common stock	Preferred Stock	Preferred Stock Series E preferred shares	Common Stock	Common Stock 2022 Notes	Common Stock 2025 Notes	Common Stock Common stock	Additional Paid-in Capital	Additional Paid-in Capital 2022 Notes	Additional Paid-in Capital 2025 Notes	Additional Paid-in Capital Series E preferred shares	Additional Paid-in Capital Common stock	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Beginning balance at Dec. 31, 2018	$ (36,525)					$ 0		$ 74				$ 546,230					$ (577,817)	$ (4,877)	$ (135)
Beginning balance, shares (in shares) at Dec. 31, 2018						0		73,980
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(40,110)																(40,125)		15
Foreign currency translation adjustment	998																	998
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan	3,265							$ 2				3,263
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (in shares)								2,254
Taxes withheld on net settled vesting of restricted stock units	(1,269)											(1,269)
Issuance of shares				$ 10,000	$ 1,439						$ 0				$ 10,000	$ 1,439
Issuance of shares (in shares)							10				263
Exercise of warrants	17,542							$ 6				17,536
Exercise of warrants (in shares)								5,477
Share-based compensation	7,302											7,302
Series E preferred stock dividends	0											361					(361)
Ending balance at Dec. 31, 2019	(37,358)					$ 0		$ 82				584,862					(618,303)	(3,879)	(120)
Ending balance, shares (in shares) at Dec. 31, 2019						10		81,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(111,186)																(111,215)		29
Foreign currency translation adjustment	(3,093)																	(3,093)
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan	5,422							$ 2				5,420
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (in shares)								2,081
Taxes withheld on net settled vesting of restricted stock units	(354)											(354)
Issuance of shares				25,000											25,000
Issuance of shares (in shares)							25
Issuance of Series E preferred stock in lieu of interest				$ 2,330											$ 2,330
Issuance of Series E preferred stock in lieu of interest (in shares)							2
Repurchase of Series E preferred stock	(2,354)											(2,354)
Repurchase of Series E preferred stock (in shares)						(2)
Issuance of common shares under settlement		$ 66,088	$ 14,354						$ 14	$ 1			$ 66,074	$ 14,353
Issuance of common shares under settlement (in shares)									13,739	1,177
Exercise of warrants	1,861							$ 0				1,861
Exercise of warrants (in shares)								338
Share-based compensation	10,419											10,419
Series E preferred stock dividends	0											2,904					(2,904)
Issuance of common shares under settlement agreement	972											972
Issuance of common shares under settlement (in shares)								90
Ending balance at Dec. 31, 2020	$ (27,899)					$ 0		$ 99				$ 711,487					$ (732,422)	$ (6,972)	$ (91)
Ending balance, shares (in shares) at Dec. 31, 2020						35		99,399

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (111,186,000)	$ (40,110,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	27,946,000	18,426,000
Fair value adjustment on derivative instrument	597,000	0
Provision for bad debts, net of recoveries	512,000	715,000
Impairment of capitalized software	1,410,000	0
Provision for excess and obsolete inventory	538,000	980,000
Share-based compensation expense	10,419,000	7,302,000
Amortization of debt discount and debt issuance costs	4,016,000	9,772,000
Loss on debt conversion and extinguishment, net	76,354,000	0
Deferred income taxes	659,000	(598,000)
Other	667,000	840,000
Changes in assets and liabilities:
Accounts receivable	(10,797,000)	377,000
Inventories	(13,336,000)	(3,077,000)
Prepaid expenses and other assets	(3,070,000)	(901,000)
Accounts payable	27,087,000	(12,996,000)
Accrued expenses, income taxes, and other	8,234,000	1,271,000
Net cash provided by (used in) operating activities	20,050,000	(17,999,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(5,736,000)	(6,621,000)
Proceeds from the sale of property, plant and equipment	392,000	517,000
Additions to capitalized software development costs and purchases of intangible assets	(29,369,000)	(22,109,000)
Net cash used in investing activities	(34,713,000)	(28,213,000)
Cash flows from financing activities:
Gross proceeds received from issuance of Series E preferred stock	25,000,000	10,000,000
Gross proceeds from the issuance of 2025 Notes	100,000,000	0
Payment of issuance costs related to 2025 Notes	(3,645,000)	0
Cash paid to investors in private exchange transactions	(32,062,000)	0
Payoff of term loan and related extinguishment costs	(48,830,000)	0
Repurchase of Series E preferred stock	(2,354,000)	0
Proceeds from the exercise of warrants to purchase common stock	1,861,000	17,542,000
Net borrowing of bank and overdraft facilities	(199,000)	(1,047,000)
Principal payments under finance lease obligations	(2,756,000)	(1,022,000)
Proceeds from stock option exercises and employee stock purchase plan, net of taxes paid on vested restricted stock units	5,066,000	1,996,000
Net cash provided by financing activities	42,081,000	27,469,000
Effect of exchange rates on cash	523,000	(259,000)
Net increase (decrease) in cash, cash equivalents and restricted cash	27,941,000	(19,002,000)
Cash, cash equivalents and restricted cash, beginning of period	12,074,000	31,076,000
Cash, and cash equivalents, end of period	40,015,000	12,074,000
Supplemental disclosures of cash flow information:
Interest	3,215,000	9,296,000
Income taxes, net of tax refunds	142,000	939,000
Supplemental disclosures of non-cash activities:
Transfer of inventories to rental assets	4,036,000	3,748,000
Purchases of property, plant and equipment under capital lease	664,000	1,341,000
Right-of-use assets obtained in exchange for operating leases liabilities	7,931,000	4,694,000
Capital expenditures financed through accounts payable or accrued liabilities	5,710,000	2,926,000
Issuance of common stock under Settlement Agreement	972,000	1,439,000
Preferred stock issued in extinguishment of term loan accrued interest	2,330,000	0
Debt discount and issuance costs extinguished in notes conversion	1,728,000	0
2022 Notes conversion to equity	59,907,000	0
Novatel Wireless Notes conversion to equity	250,000	0
2025 Notes issued to extinguish 2022 Notes	80,375,000	0
2025 Notes conversion, including shares issued in satisfaction of interest-make-whole payment	$ 14,353,000	$ 0

Nature of Business and Significant Accounting Policies

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Nature of Business and Significant Accounting Policies

Inseego Corp. (the “Company” or “Inseego”) is a leader in the design and development of fixed and mobile wireless solutions (advanced 4G and 5G New Radio (“5G NR”)), industrial Internet of Things (“IIoT”) and cloud solutions for large enterprise verticals, service providers and small and medium-sized businesses around the globe. Inseego’s customers include wireless service providers, fortune 500 enterprises, consumers, governments, and first responders. Product portfolio consists of fixed and mobile device-to-cloud solutions that provide compelling, intelligent, reliable and secure end-to-end IoT services with deep business intelligence. Inseego’s products and solutions, designed and developed in the U.S., power mission critical applications with a “zero unscheduled downtime” mandate, such as our 5G fixed wireless access (“FWA”) gateway solutions, 4G and 5G mobile broadband, IIoT applications such as SD WAN failover management, asset tracking and fleet management services. Inseego’s solutions are powered by its key wireless innovations in mobile and FWA technologies, including a suite of products employing the 5G NR standards, and purpose-built SaaS cloud platforms.

Inseego is a Delaware corporation formed in 2016 and is the successor to Novatel Wireless, Inc., a Delaware corporation formed in 1996 (“Novatel Wireless”), resulting from an internal reorganization that was completed in November 2016. The Company’s principal executive office is located at 12600 Deerfield Parkway, Suite 100, Alpharetta, GA 30004, its corporate offices are located at 9710 Scranton Road, Suite 200, San Diego CA 92121 and its sales and engineering offices are located throughout the world. Inseego’s common stock trades on The NASDAQ Global Select Market under the trading symbol “INSG”.

Basis of Presentation

The Company had a net loss attributable to Inseego Corp. of $111.2 million during the year ended December 31, 2020. As of December 31, 2020, the Company had available cash and cash equivalents totaling $40.0 million and working capital of $38.4 million. The Company has a history of operating and net losses and overall usage of cash from operating and investing activities.

On March 6, 2020, the Company issued and sold 25,000 shares of Fixed-Rate Cumulative Perpetual Preferred Stock, Series E, par value $0.001 per share (the “Series E Preferred Stock”), for an aggregate purchase price of $25.0 million.

In the first quarter of 2020, $59.9 million of the Company’s 5.5% convertible senior notes due 2022 (the “2022 Notes” formerly referred to as the “Inseego Notes”) were exchanged for common stock in private exchange transactions. Additionally, in the second quarter of 2020, the Company restructured its outstanding debt by completing a $100.0 million registered public offering (the “Offering”) of 3.25% convertible senior notes due 2025 (the “2025 Notes”) and also entered into privately-negotiated exchange agreements (“Exchange Agreements”), pursuant to which an aggregate of $45.0 million in principal amount of the 2022 Notes were exchanged for an aggregate of $32.0 million in cash and $80.4 million in principal amount of the 2025 Notes (the “Private Exchange Transactions”). The Company also used a portion of the proceeds from the Offering to repay in full its previous term loan. In the third quarter of 2020, the Company redeemed the remaining $2,000 principal amount of the 2022 Notes.

During the quarter ended September 30, 2020, certain holders of the 2025 Notes converted approximately $13.5 million in principal amount of the 2025 Notes into 1,177,156 shares of the Company’s common stock in accordance with the terms of such notes. As of December 31, 2020, the Company’s outstanding debt primarily consisted of $166.9 million in principal amount of 2025 Notes.

Additionally, in January 2021, the Company sold 1,516,073 shares of common stock, at a public offering price of $20.11 per share, for net proceeds of $29.6 million, pursuant to the ATM Offering. See Note 15, Subsequent Events.

The Company has a history of operating and net losses and overall usage of cash from operating and investing activities. The Company’s management believes that its cash and cash equivalents, together with anticipated cash flows from operations, will be sufficient to meet its cash flow needs for the next twelve months from the filing date of this report. The Company’s ability to attain more profitable operations and continue to generate positive cash flow is dependent upon achieving a level and mix of revenues adequate to support its evolving cost structure. If events or circumstances occur such that the Company does not meet its operating plan as expected, or if the Company becomes obligated to pay unforeseen expenditures as a result of ongoing litigation, the Company may be required to raise capital, reduce planned research and development activities, incur additional restructuring charges or reduce other operating expenses which could have an adverse impact on its ability to achieve its intended business objectives.

The Company’s liquidity could be impaired if there is any interruption in its business operations, a material failure to satisfy its contractual commitments or a failure to generate revenue from new or existing products. There can be no assurance that any required or desired restructuring or financing will be available on terms favorable to the Company, or at all.

Additionally, the Company is uncertain of the full extent to which the COVID-19 pandemic will impact the Company’s business, operations and financial results.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent liabilities. Actual results could differ materially from these estimates. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the novel coronavirus pandemic ("COVID-19") could have on our significant accounting estimates. Significant estimates include revenue recognition, capitalized software costs, allowance for doubtful accounts receivable, provision for excess and obsolete inventory, valuation of intangible and long-lived assets, valuation of goodwill, valuation of derivatives, accruals relating to litigation, income taxes, and share-based compensation expense.

Segment Information

Management has determined that the Company has one reportable segment. The Chief Executive Officer, who is also the Chief Operating Decision Maker, does not manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and operating results.

Cash and Cash Equivalents

Cash and cash equivalents include highly liquid investments with original maturities of three months or less. Cash and cash equivalents are recorded at market value, which approximates cost. Gains and losses associated with the Company’s foreign currency denominated demand deposits are recorded as a component of other income, net, in the consolidated statements of operations.

Allowance for Doubtful Accounts Receivable

The Company provides an allowance for its accounts receivable for estimated losses that may result from its customers’ inability to pay. The Company determines the amount of the allowance by analyzing known uncollectible accounts, aged receivables, economic conditions, historical losses, and changes in customer payment cycles and its customers’ creditworthiness. Amounts later determined and specifically identified to be uncollectible are charged or written off against this allowance. To minimize the likelihood of uncollectibility, the Company reviews its customers’ creditworthiness periodically based on credit scores generated by independent credit reporting services, its experience with its customers and the economic condition of its customers’ industries. Material differences may result in the amount and timing of expense for any period if the Company were to make different judgments or utilize different estimates.

Inventories and Provision for Excess and Obsolete Inventory

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Shipping and handling costs are classified as a component of cost of net revenues in the consolidated statements of operations. The Company reviews the components of its inventory and its inventory purchase commitments on a regular basis for excess and obsolete inventory based on estimated future usage and sales. Write-downs in inventory value or losses on inventory purchase commitments depend on various items, including factors related to customer demand, economic and competitive conditions, technological advances or new product introductions by the Company or its customers that vary from its current expectations. Whenever inventory is written down, a new cost basis is established and the inventory is not subsequently written up if market conditions improve.

The Company believes that, when made, the estimates used in calculating the inventory provision are reasonable and properly reflect the risk of excess and obsolete inventory. If customer demand for the Company’s inventory is substantially less than its estimates, inventory write-downs may be required, which could have a material adverse effect on its consolidated financial statements.

Property, Plant and Equipment

Property, plant and equipment are initially stated at cost and depreciated using the straight-line method. Land is not depreciated. Buildings are depreciated over 50 years. Leasehold improvements are depreciated over the shorter of the related

remaining lease period or useful life, not to exceed 5 years. Product tooling is depreciated over 13 months. Computer equipment, purchased software, vehicles, production equipment, and furniture and fixtures, are depreciated over lives ranging from 2 to 5 years. Amortization of equipment under capital leases is included in depreciation expense.

Expenditures for repairs and maintenance are expensed as incurred. Expenditures for major renewals and betterments that extend the useful lives of existing property, plant and equipment are capitalized and depreciated. Upon retirement or disposition of property, plant and equipment, any resulting gain or loss is recognized in other income, net, in the consolidated statements of operations.

Rental Assets

The cost of rental assets, which represents fleet management and vehicle tracking hardware installed in customers’ vehicles where such hardware is provided as part of a fixed term contract with the customer, is capitalized and disclosed separately in the consolidated balance sheets. The Company depreciates rental assets to costs of net revenues on a straight-line basis over the term of the contract, generally three to four years, commencing on installation of the rental asset.

Research and development

Research and development expense consists primarily of personnel costs for our engineers engaged in the design and development of our products, software and technologies, including salary, bonus and share‐based compensation expense, project material costs, services, depreciation and amortization. Such costs are charged to research and development expense as they are incurred, to the extent not capitalized as software development costs for external or internal use.

Software Development Costs for External Use

Software development costs for external use are expensed as incurred until technological feasibility has been established, at which time those costs are capitalized as intangible assets until the software is implemented into products sold to customers. Capitalized software development costs are amortized on a straight-line basis over the estimated useful life. The straight-line recognition method approximates the manner in which the expected benefit will be derived. Costs incurred to enhance existing software or after the implementation of the software into a product are expensed in the period they are incurred and included in research and development expense in the consolidated statements of operations.

Software Development Costs for Internal Use

Costs incurred in the preliminary stages of development are expensed as incurred and included in research and development expense in the consolidated statements of operations. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing performed to ensure the product is ready for its intended use. The Company also capitalizes costs related to specific upgrades and enhancements of internal-use software when it is probable that the expenditures will result in additional functionality. Maintenance and training costs are expensed as incurred. Capitalized internal-use software costs are recorded as part of intangible assets and are amortized on a straight-line basis over the estimated useful life of the software. The Company tests these assets for impairment whenever events or circumstances occur that could impact their recoverability. For the year ended December 31, 2020 and 2019, the Company recorded $1.4 million and $0 of impairment loss, respectively, related to software development costs for internal use.

Intangible Assets

Intangible assets include purchased finite-lived and indefinite-lived intangible assets resulting from the acquisitions of DigiCore Holdings Limited (“DigiCore” or “Ctrack”) and R.E.R. Enterprises, Inc. (“RER”) and its wholly owned subsidiary and principal operating asset, Feeney Wireless, LLC (which was renamed Inseego North America, LLC) (“INA”), along with the costs of non-exclusive and perpetual worldwide software technology licenses and capitalized software developments costs for both internal and external use. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets (see Note 3, Goodwill and Other Intangible Assets).

Indefinite-lived assets, including goodwill and in-process capitalized software development costs, are not amortized; however, they are tested for impairment annually, and between annual tests, if certain events occur indicating that the carrying amounts may be impaired. The Company performs an annual impairment review of indefinite-lived assets during the fourth fiscal quarter of each year, and more frequently if we believe indicators of impairment exist. To review for impairment, we first assess qualitative factors to determine whether events or circumstances lead to a determination that it is more likely than not that the fair value of the Company’s reporting unit is less than its carrying amount. The Company’s qualitative assessment of the recoverability of indefinite-lived assets was based on various macroeconomic, industry-specific, and company specific

factors. These factors include: (i) industry or economic trends; (ii) current, historical, or projected financial performance, and; (iii) the Company’s market capitalization. After assessing the totality of events and circumstances, if the Company determines that it is not more likely than not that the fair value of the Company’s reporting unit is less than its carrying amount, no further assessment is performed. If the Company determines that it is more likely than not that the fair value of the Company’s reporting unit is less than its carrying amount, the Company calculates the fair value of the reporting unit and compares the fair value to the reporting unit’s net book value. For the years ended December 31, 2020 and 2019, the Company recorded no impairment loss related to indefinite-lived intangible assets.

Long-Lived Assets

The Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, plant and equipment, rental assets and intangible assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods should be made. When the carrying value of an asset exceeds the associated undiscounted expected future cash flows, it is considered to be impaired and is written down to fair value. Fair value is determined based on an evaluation of the assets’ associated undiscounted future cash flows or appraised value. This evaluation is based on management’s projections of the undiscounted future cash flows associated with each class of asset. If management’s evaluation indicates that the carrying values of these assets are impaired, such impairment is recognized by a reduction of the applicable asset carrying value to its estimated fair value and the impairment is expensed as a part of continuing operations. For the year ended December 31, 2020 and 2019, the Company had no impairment loss related to long-lived assets, except for the impairment of the capitalized software development costs for internal use, noted above.

Convertible Debt Instruments

The Company evaluates embedded features within convertible debt that will be settled in shares upon conversion under Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”) to determine whether the embedded feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings.

If an embedded derivative is bifurcated from share-settled convertible debt, the Company records the debt component at cost less a debt discount equal to the bifurcated derivative’s fair value. The Company amortizes the debt discount over the life of the debt instrument as additional non-cash interest expense utilizing the effective interest method. The convertible debt and the derivative liability are presented in total on the consolidated balance sheet. The derivative liability will be remeasured at each reporting period with changes in fair value recorded in the consolidated statements of operations in other income, net.

Derivative Financial Instruments

The Company evaluates stock warrants, debt instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for under the relevant sections of the Financial Accounting Standards Board (the “FASB”) ASC. The result of this accounting treatment could be that the fair value of a financial instrument is classified as a derivative financial instrument and is marked-to-market at each balance sheet date and recorded as an asset or liability. In the event that the fair value is recorded as an asset or liability, the change in fair value is recorded in the consolidated statements of operations as other income or other expense. Upon conversion, exercise or expiration of a derivative financial instrument, the instrument is marked to fair value.

Revenue Recognition

The Company generates revenue from a broad range of product sales including intelligent wireless hardware products for the worldwide mobile communications and industrial IoT markets. The Company’s products principally include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking hardware devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware.

The Company classifies its revenues from the sale of its products and services into two distinct groupings, specifically IoT & Mobile Solutions and Enterprise SaaS Solutions. Both IoT & Mobile Solutions and Enterprise SaaS Solutions revenues include any hardware and software required for the respective solution.

Net revenues by product grouping for the years ended December 31, 2020 and 2019 were as follows (in thousands):


	Year Ended December 31,
	2020		2019
IoT & Mobile Solutions	$	261,169	$	160,873
Enterprise SaaS Solutions	52,663		58,623
Total	$	313,832	$	219,496

See geographic disaggregation information in Note 12, Geographic Information and Concentrations of Risk.

IoT & Mobile Solutions. The IoT & Mobile Solutions portfolio is comprised of end-to-end edge to cloud solutions including 4G LTE mobile broadband gateways, routers, modems, hotspots, HD quality VoLTE based wireless home phones, cloud management software and an advanced 5G portfolio of products (currently in various stages of development). The solutions are offered under the MiFi and MiFiTM brands for consumer and business markets, and under the Skyus brand for industrial IoT markets. Effective in the third quarter ended on September 30, 2020, IoT & Mobile Solutions now also includes the Company’s Device Management System (“DMS”), rebranded as Inseego SubscribeTM , a hosted SaaS platform that helps organizations manage the selection, deployment and spend of their customer’s wireless assets, helping them save money on personnel and telecom expenses. The Company reclassified its Inseego Subscribe revenue stream from Enterprise SaaS Solutions to better reflect the Company's end user delineation. This reclassification had no impact on previously reported total net revenue, gross profit, or net loss.

Enterprise SaaS Solutions. The Enterprise SaaS Solutions consist of various subscription offerings to gain access to the Company’s Ctrack telematics platforms, which provide fleet vehicle, aviation ground vehicle and asset tracking and performance information, and other telematics applications.

Contracts with Customers

The Company follows Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606) (as amended, “ASC 606”), which provides guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

The Company routinely enters into a variety of agreements with customers, including quality agreements, pricing agreements and master supply agreements which outline the general commercial terms and conditions under which the Company does business with a specific customer, including shipping terms and pricing for the products and services that the Company offers. The Company also sells to some customers solely based on purchase orders. The Company has concluded, for the vast majority of its revenues, that its contracts with customers are either a purchase order or the combination of a purchase order with a master supply agreement.

The Company determines revenue recognition through the following five steps:

1)identification of the contract, or contracts, with a customer;

2)identification of the performance obligations in the contract;

3)determination of the transaction price;

4)allocation of the transaction price to the performance obligations in the contract; and

5)recognition of revenue when, or as, performance obligations are satisfied.

The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

The Company’s performance obligations are established when a customer submits a purchase order notification (in writing, electronically or verbally) for goods and services, and the Company accepts the order. The Company identifies performance obligations as the delivery of the requested product or service in appropriate quantities and to the location specified in the customer’s contract and/or purchase order. The Company generally recognizes revenue upon the satisfaction of these criteria when control of the product or service has been transferred to the customer at which time it has an unconditional right to receive payment. The Company’s prices are fixed and have no history of being affected by contingent events that could

impact the transaction price. The Company does not offer price concessions and does not accept payment that is less than the price stated when it accepts the purchase order.

Revenue Recognition

Revenue is recognized upon transfer of control of products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that may include various combinations of products and services which are generally capable of being distinct and accounted for as separate performance obligations.

Hardware. Hardware revenue from the sale of the Company’s IoT & Mobile Solutions devices is recognized when the Company transfers control to the customer, typically at the time when the product is delivered, shipped or installed at which time the title passes to the customer, and there are no further performance obligations with regards to the hardware device.

SaaS and Other Services. SaaS subscription revenue is recognized over time on a ratable basis over the contract term beginning on the date that its service is made available to the customer. Subscription periods range from monthly to multi-year, with the majority of contracts being one to three years. Telematics includes a device which collects and transmits the information from the vehicle or other asset. The Company’s customers have an option to purchase the monitoring device or lease it over the term of the contract. If the customer purchases the hardware device, the Company recognizes the revenue at a point in time as discussed above in the hardware revenue recognition disclosure. Because the Company’s rental asset lease contracts qualify as operating leases under ASC 842, Leases (“ASC 842”), and the contracts also include services to operate the underlying asset, and to maintain the asset, the Company has elected the practical expedient to combine the lease and the non-lease components because the service is the predominant element in the eyes of the customer and the pattern of service delivery is the same for both elements. The Company recognizes revenue over time on a ratable basis over the term of the contract.

Maintenance and support services revenue. Periodically, the Company sells separately-priced warranty contracts that extend beyond the Company’s base warranty period. The separately priced service contracts range from 12 months to 36 months. The Company typically receives payment at the inception of the contract and recognizes revenue as earned on a straight-line basis over the term of the contract.

Professional services revenue. From time to time, the Company enters into special engineering design service agreements. Revenues from engineering design services are designed to meet specifications of a particular product, and therefore do not create an asset with an alternative use. The Company recognizes revenue based on the achievement of certain applicable milestones and the amount of payment the Company believes it is entitled to at the time.

With respect to revenue related to third party product sales or other arrangements that involve the services of another party, for which the Company does not control the sale or service and acts as an agent to the transaction, the Company recognizes revenue on a net basis. The portion of the gross amount billed to customers that is remitted by the Company to another party is not reflected as revenue.

Multiple Performance Obligations

The Company’s contracts with customers may include commitments to transfer multiple products and services to a customer. When hardware, software and services are sold in various combinations, judgment is required to determine whether each performance obligation is considered distinct and accounted for separately, or not distinct and accounted for together with other performance obligations. The Company considered the performance obligations in its customer master supply agreements and determined that, for the majority of its revenue, the Company generally satisfies performance obligations at a point in time upon delivery of the product to the customer.

In instances where the software elements included within hardware for various products are considered to be functioning together with non-software elements to provide the tangible product’s essential functionality, these arrangements are accounted for as a single distinct performance obligation.

Judgment is required to determine the stand-alone selling price (“SSP”) for each distinct performance obligation. When available, the Company uses observable inputs to determine SSP. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, it determines the SSP based on a cost-plus model as market and other observable inputs are seldom present based on the proprietary nature of the Company’s products.

Contract Liabilities

Timing of revenue recognition may differ from the timing of invoicing to customers. If customers are invoiced for subscription services in advance of the service period, deferred revenue liabilities, or contract liabilities, are recorded. Deferred revenue liabilities, or contract liabilities, are also recorded when the Company collects payments in advance of performing the services.

Contract Assets

The Company capitalizes sales commissions earned by its sales force when they are considered to be incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit. There were no significant amounts of assets recorded related to contract costs as of December 31, 2020.

Applying the practical expedient in paragraph 40-25-4 of ASC 340, Other Assets and Deferred Costs, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in selling, general and administrative expenses.

Significant Judgments in the Application of the Guidance in ASC 606

Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. The Company considered the performance obligations in its customer master supply agreements and determined that, for the majority of its revenue, the Company generally satisfies performance obligations at a point in time upon delivery of the product to the customer.

Revenues from the Company’s SaaS subscription services represent a single promise to provide continuous access to its software solutions and their processing capabilities in the form of a service through one of the Company’s data centers or a hosted data center. As each day of providing access to the software is substantially the same, and the customer simultaneously receives and consumes the benefits as access is provided, the Company has determined that its subscription services arrangements include a single performance obligation comprised of a series of distinct services. The Company’s SaaS subscriptions also include an unspecified volume of call center support and any remote system diagnostic and software upgrades as needed. These services are combined with the recurring monthly subscription service since they are highly interrelated and interdependent. Revenue from the Company’s subscription services is recognized over time on a ratable basis over the contract term beginning on the date that the service is made available to the customer.

Shipping and Handling Charges

Fees charged to customers for shipping and handling of products are included in product revenues, and costs for shipping and handling of products are included as a component of cost of sales.

Taxes Collected from Customers

Taxes collected on the value of transaction revenue are excluded from product and services revenues and cost of sales and are accrued in current liabilities until remitted to governmental authorities.

Foreign Currency Transactions

Foreign currency transactions are transactions denominated in a currency other than a subsidiary’s functional currency. A change in the exchange rates between a subsidiary’s functional currency and the currency in which a transaction is denominated increases or decreases the expected amount of functional currency cash flows upon settlement of the transaction. That increase or decrease in expected functional currency cash flows is reported by the Company as a foreign currency transaction gain (loss). The primary component of the Company’s foreign currency transaction gain (loss) is due to agreements in place with certain subsidiaries in foreign countries regarding intercompany transactions. Based upon historical experience, the Company anticipates repayment of these transactions in the foreseeable future, and recognizes the realized and unrealized gains (losses) on these transactions that result from foreign currency changes in the period in which they occur as foreign currency transaction gain (loss), which is recorded as other income, net, in the consolidated statements of operations.

Foreign Currency Translation

Assets and liabilities of the Company’s international subsidiaries in which the local currency is the functional currency are translated into U.S. Dollars at period-end exchange rates. Income and expenses are translated into U.S. Dollars at the average

exchange rates during the period. The resulting translation adjustments are included in the Company’s consolidated balance sheets as a component of accumulated other comprehensive loss.

Income Taxes

The Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable to or refundable by tax authorities in the current fiscal year. The Company also recognizes federal, state and foreign deferred tax liabilities or assets based on the Company’s estimate of future tax effects attributable to temporary differences and carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

Deferred tax assets are reduced by valuation allowances if, based on the consideration of all available evidence, it is more likely than not that some portion of the deferred tax asset will not be realized. The Company evaluates deferred income taxes on a quarterly basis to determine if valuation allowances are required by considering available evidence. If the Company is unable to generate sufficient future taxable income in certain tax jurisdictions, or if there is a material change in the actual effective tax rates or time period within which the underlying temporary differences become taxable or deductible, the Company could be required to increase its valuation allowance against its deferred tax assets which could result in an increase in the Company’s effective tax rate and an adverse impact on operating results. The Company will continue to evaluate the necessity of the valuation allowance based on the remaining deferred tax assets.

The Company follows the accounting guidance related to financial statement recognition, measurement and disclosure of uncertain tax positions. The Company recognizes the impact of an uncertain income tax position on an income tax return at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Uncertain tax positions are recognized in the first subsequent financial reporting period in which that threshold is met or from changes in circumstances such as the expiration of applicable statutes of limitations.

Litigation

The Company is, from time to time, party to various legal proceedings arising in the ordinary course of business. The Company records a loss when information indicates that a loss is both probable and estimable. Where a liability is probable and there is a range of estimated loss with no best estimate in the range, the Company records the minimum estimated liability related to the claim. As additional information becomes available, the Company assesses the potential liability related to the Company’s pending litigation and revises its estimates, if necessary. The Company expenses litigation costs as incurred.

Share-Based Compensation

The Company has granted stock options and RSUs to employees, non-employee consultants and non-employee members of our Board of Directors. The Company also has an employee stock purchase plan (“ESPP”) for eligible employees. The Company measures the compensation cost associated with all share-based payments based on grant date fair values. The fair value of each stock option and stock purchase right is estimated on the date of grant using an option pricing model that meets certain requirements. The Company generally uses the Black-Scholes option pricing model to estimate the fair value of its stock options and stock purchase rights. The Black-Scholes model is considered an acceptable model but the fair values generated by it may not be indicative of the actual fair values of the Company’s equity awards as it does not consider certain factors important to those awards to recipients, such as continued service and periodic vesting requirements, as well as limited transferability. The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by the Company’s stock price and a number of assumptions, including expected volatility, expected term, risk-free interest rate and expected dividends.

For grants of stock options, the Company uses a blend of historical and implied volatility for traded options on its stock in order to estimate the expected volatility assumption required in the Black-Scholes model. The Company’s use of a blended volatility estimate in computing the expected volatility assumption for stock options is based on its belief that while the implied volatility is representative of expected future volatility, the historical volatility over the expected term of the award is also an indicator of expected future volatility. Due to the short duration of stock purchase rights under the Company’s ESPP, the Company utilizes historical volatility in order to estimate the expected volatility assumption of the Black-Scholes model.

The expected term of stock options granted is estimated using historical experience. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the Company’s stock options and stock purchase rights. The dividend yield assumption is based on the Company’s history and expectation of no dividend payouts. The Company

estimates forfeitures at the time of grant and revises these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates its forfeiture rate assumption for all types of share-based compensation awards based on historical forfeiture rates related to each category of award.

Compensation cost associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the Company’s common stock on the date of grant.

The Company recognizes share-based compensation expense over the requisite service period of each individual award, which generally equals the vesting period, using the straight-line method for awards that contain only service conditions. For awards that contain performance conditions, the Company recognizes the share-based compensation expense on a straight-line basis for each vesting tranche.

The Company evaluates the assumptions used to value stock awards on a quarterly basis. If factors change and the Company employs different assumptions, share-based compensation expense may differ significantly from what it has recorded in the past. If there are any modifications or cancellations of the underlying unvested securities, the Company may be required to accelerate, increase or cancel any remaining unearned share-based compensation expense.

Net Loss Per Share Attributable to Inseego Corp.

The Company computes basic and diluted per share data for all periods for which a statement of operations is presented. Basic net loss per share excludes dilution and is computed by dividing the net loss by the weighted-average number of shares that were outstanding during the period. Diluted earnings per share (“EPS”) reflects the potential dilution that could occur if securities or other contracts to acquire common stock were exercised or converted into common stock. Potential dilutive securities are excluded from the diluted EPS computation in loss periods as their effect would be anti-dilutive.

Fair Value of Financial Instruments

The Company’s fair value measurements relate to its cash equivalents and money market funds, which are classified pursuant to authoritative guidance for fair value measurements. The Company places its cash equivalents in instruments that meet credit quality standards, as specified in its investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

The Company’s financial instruments consist principally of long-term debt. From time to time, the Company may utilize foreign exchange forward contracts. These contracts are valued using pricing models that take into account the currency rates as of the balance sheet date.

Comprehensive Loss

Comprehensive loss consists of net earnings and foreign currency translation adjustments.

Prior Period Reclassifications

Certain amounts in prior periods have been reclassified to conform with current period presentation.

New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB, which are adopted by the Company as of the specified date.

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU

removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected credit losses for financial assets

held. This guidance is effective for interim and annual periods beginning after December 15, 2019. There was no impact from the adoption of this pronouncement to the Company’s consolidated financial statements.

Financial Statement Details

12 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Financial Statement Details

Inventories

Inventories consist of the following (in thousands):


	December 31,
	2020		2019
Finished goods	$	27,009	$	21,229
Raw materials and components	6,943		4,061
	$	33,952	$	25,290

Property, Plant and Equipment

Property, plant and equipment consists of the following (in thousands):


	December 31,
	2020		2019
Land	$	244	$	253
Buildings	2,213		2,303
Test equipment	16,775		10,952
Computer equipment and purchased software	7,899		6,911
Product tooling	3,125		2,139
Furniture and fixtures	1,310		1,535
Vehicles	2,988		2,535
Leasehold improvements	860		145
	35,414		26,773
Less—accumulated depreciation and amortization	(21,715)		(16,017)
	$	13,699	$	10,756

At December 31, 2020, the Company had vehicles and equipment under finance leases with an aggregate carrying value of $2.6 million, net of accumulated amortization of $1.0 million. At December 31, 2019, the Company had vehicles and equipment under finance leases with an aggregate carrying value of $2.1 million, net of accumulated amortization of $2.6 million.

Rental Assets

Rental assets consist of the following (in thousands):


	December 31,
	2020		2019
Rental assets	$	21,863	$	18,176
Less—accumulated depreciation	(15,754)		(12,791)
	$	6,109	$	5,385

Depreciation and amortization expense related to property, plant and equipment, including equipment under capital leases, and rental assets was $10.0 million and $8.8 million for the years ended December 31, 2020 and 2019, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	December 31,
	2020		2019
Royalties	$	2,410	$	1,415
Payroll and related expenses	6,006		2,716


Professional fees	921		483

Accrued interest	888		1,543
Deferred revenue	2,853		2,235

Operating lease liabilities	1,619		1,101
Acquisition-related liabilities	—		1,000

Other	8,676		7,555
	$	23,373	$	18,048

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

A summary of the activity in goodwill is presented below (in thousands):


Balance at December 31, 2018	$	32,942




Effect of change in foreign currency exchange rates	717
Balance at December 31, 2019	33,659


Effect of change in foreign currency exchange rates	(1,148)
Balance at December 31, 2020	$	32,511

The Company’s intangible assets are comprised of the following (in thousands):


	December 31, 2020
	Weighted-Average Life (in years)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Finite-lived intangible assets:
Developed technologies	6.0	$	12,692	$	(10,878)	$	1,814
Trademarks and trade names	10.0	17,823		(9,597)		8,226
Customer relationships	8.5	12,306		(8,703)		3,603
Capitalized software development costs	3.3	47,818		(31,051)		16,767
Other	2.5	3,389		(2,791)		598
Total finite-lived intangible assets		$	94,028	$	(63,020)	31,008
Indefinite-lived intangible assets:
In-process capitalized software development costs						20,479
Total intangible assets						$	51,487


	December 31, 2019
	Weighted-Average Life (in years)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Finite-lived intangible assets:
Developed technologies	6.0	$	13,076	$	(9,198)	$	3,878
Trademarks and trade names	10.0	18,352		(8,040)		10,312
Customer relationships	8.4	12,460		(7,413)		5,047
Capitalized software development costs	3.6	19,375		(6,570)		12,805
Other	2.4	2,986		(1,790)		1,196
Total finite-lived intangible assets		$	66,249	$	(33,011)	33,238
Indefinite-lived intangible assets:
In-process capitalized software development costs						11,154
Total intangible assets						$	44,392

Amortization expense for the years ended December 31, 2020 and 2019 was approximately $18.0 million and $9.7 million, respectively, including approximately $12.9 million and $4.1 million related to capitalized software development costs for the years ended December 31, 2020 and 2019, respectively.

The Company recorded a $1.4 million impairment loss on intangible assets during the years ended December 31, 2020 and no impairment loss during the year ended December 31, 2019.

The following table represents details of the amortization of finite-lived intangible assets that is estimated to be expensed in the future (in thousands):


2021	13,026
2022	7,390
2023	4,383
2024	3,937
2025	2,272

Total	$	31,008

Fair Value Measurement of Assets and Liabilities

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement of Assets and Liabilities

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). A fair value measurement reflects the assumptions market participants would use in pricing an asset or liability based on the best available information. These assumptions include the risk inherent in a particular valuation technique (such as a pricing model) and the risks inherent in the inputs to the model.

The Company classifies inputs to measure fair value using a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) and is defined as follows:

Level 1: Pricing inputs are based on quoted market prices for identical assets or liabilities in active markets (e.g., NYSE or NASDAQ). Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Pricing inputs include benchmark yields, trade data, reported trades and broker dealer quotes, two-sided markets and industry and economic events, yield to maturity, Municipal Securities Rule Making Board reported trades and vendor trading platform data. Level 2 includes those financial instruments that are valued using various pricing services and broker pricing information including Electronic Communication Networks and broker feeds.

Level 3: Pricing inputs include significant inputs that are generally less observable from objective sources, including the Company’s own assumptions.

The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There have been no transfers of assets or liabilities between fair value measurement classifications during the year ended December 31, 2020.

The following table summarizes the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of December 31, 2020 (in thousands):


	Balance as of December 31, 2020		Level 1
Assets:
Cash equivalents
Money market funds	$	126	$	126

Total cash equivalents	$	126	$	126


	Balance as of December 31, 2019		Level 1
Assets:
Cash equivalents
Money market funds	$	126	$	126

Total cash equivalents	$	126	$	126


	Balance as of December 31, 2020		Level 3
Liabilities:
2025 Notes
Interest make-whole payment	$	4,898	$	4,898

Total embedded derivatives	$	4,898	$	4,898

The fair value of the interest make-whole payment derivative liability was determined using a Monte Carlo model with the following key assumptions:


	May 12, 2020		December 31, 2020
Volatility	60	%	50	%
Stock price	$10.62 per share		$15.47 per share
Credit spread	14.97	%	19.25	%
Term	4.97 years		4.34 years
Dividend yield	—	%	—	%
Risk-free rate	0.34	%	0.30	%

The following table sets forth a summary of changes in the fair value of Level 3 liabilities for the twelve months ended December 31, 2020 (in thousands):


	Balance as of December 31, 2019		Additions		Conversions		Change in fair value		Balance as of December 31, 2020
Liabilities:
Interest make-whole payment	$	—	$	4,582	$	(281)	$	597	$	4,898

The Company evaluated the 2025 Notes under ASC 815, Derivatives and Hedging, and identified an embedded derivative that required bifurcation. The embedded derivative is an interest make-whole payment that was valued at $4.6 million on May 12, 2020.

The estimated fair value of the interest make-whole derivative liability at the date of issuance was determined using significant assumptions which include an implied credit spread rate for notes with a similar term, the expected volatility and dividend yield of the Company’s common stock and the risk-free interest rate.

Changes in the fair value of the interest make-whole payment are included in the Company’s consolidated statement of operations for the current fiscal year within other income, net. During the year ended December 31, 2020, certain holders of the 2025 Notes converted an aggregate of approximately $13.5 million in principal amount of the 2025 Notes into shares of the Company’s common stock in accordance with the terms of such notes and a portion of the embedded derivative was settled in shares of the Company’s common stock resulting in $0.3 million of the derivative liability being extinguished upon conversion. As of December 31, 2020, the embedded derivative had a fair value of $4.9 million and a $0.6 million loss on the change in fair value was recorded to other income (expense), net, on the consolidated statement of operations.

During the years ended December 31, 2020 and 2019, there were no transfers between the levels within the fair value hierarchy.

Other Financial Instruments

The Company’s financial assets and liabilities are carried at fair value or at amounts that, because of their short-term nature, approximate current fair value, with the exception of the 2025 Notes and 2022 Notes. (See Note 5, Debt).

The Company carries its 2025 Notes at amortized cost adjusted for changes in fair value of the embedded derivative. It is not practicable to determine the fair value of the 2025 Notes due to the lack of information available to calculate the fair value of such notes.

Debt

12 Months Ended

Dec. 31, 2020

Debt Disclosure [Abstract]

Debt

Long-Term Debt

Term Loan

On August 23, 2017, the Company and certain of its direct and indirect subsidiaries (the “Guarantors”) entered into a credit agreement (the “Credit Agreement”) with Cantor Fitzgerald Securities, as administrative agent and collateral agent, and certain lenders (the “Lenders”). Pursuant to the Credit Agreement, the Lenders provided the Company with a term loan in the principal amount of $48.0 million (the “Term Loan”) with a maturity date of August 23, 2020 (the “Maturity Date”). In conjunction with the closing of the Term Loan, the Company received proceeds of $46.9 million, $35.0 million of which was funded to the Company in cash on the closing date, net of an original issue discount and commitment fee, and the remaining $11.9 million of which was funded through the Company’s repurchase and cancellation of approximately $14.9 million of its then outstanding 2022 Notes pursuant to the terms of the Note Purchase Agreement (as defined below). The Company paid issuance costs of approximately $0.5 million. Additionally, the Company issued shares of its common stock and accrued an exit fee, which, when combined with the original debt discount and commitment fee, resulted in a total debt discount of approximately $4.0 million.

On March 31, 2020, the Company issued 2,330 shares of Series E Preferred Stock to South Ocean Funding L.L.C. (“South Ocean”), the Lender holding all of the aggregate principal amount then outstanding under the Credit Agreement in satisfaction of all then accrued interest under the Credit Agreement.

On May 12, 2020, the Company used a portion of the proceeds from the Offering to repay in full the Term Loan and terminate the Credit Agreement. The amounts paid included $47.5 million in outstanding principal, approximately $0.5 million in interest accrued thereon, and prepayment and exit fees of $1.4 million. The Company also used a portion of the proceeds of the Offering to repurchase the 2,330 shares of Series E Preferred Stock that had been issued to South Ocean for $2.4 million.

The Term Loan bore interest at a rate per annum equal to the three-month LIBOR, but in no event less than 1.00%, plus 7.625%.

The Term Loan consisted of the following (in thousands):


	December 31,
	2019
Principal	$	47,500
Less: unamortized debt discount and debt issuance costs	(962)
Net carrying amount	$	46,538

The effective interest rate on the Term Loan was 15.19% for the year ended December 31, 2020. The following table sets forth total interest expense recognized related to the Term Loan during the years ended December 31, 2020 and 2019 (in thousands):


	Year Ended December 31,
	2020		2019
Contractual interest expense	$	1,667	$	4,789
Amortization of debt discount	859		1,331
Amortization of debt issuance costs	103		161
Total interest expense	$	2,629	$	6,281

Convertible Notes

2025 Notes

On May 12, 2020, the Company completed its registered public Offering of $100.0 million aggregate principal amount of 2025 Notes.

On May 12, 2020, the Company also entered into Exchange Agreements with certain related party holders of the 2022 Notes. Pursuant to the Exchange Agreements, these noteholders agreed to exchange the 2022 Notes that they held (representing an aggregate of $45.0 million principal amount of 2022 Notes with an estimated fair value of approximately $112.4 million as of the date of exchange) for an aggregate of $32.0 million in cash and $80.4 million principal amount of 2025 Notes in private placement transactions that closed concurrently with the registered Offering. In connection therewith, the Company recorded $67.2 million in loss on debt conversion and extinguishment, net in the consolidated statement of operations. The 2025 Notes issued in the Private Exchange Transactions are part of the same series as the 2025 Notes issued in the registered Offering.

During the year ended December 31, 2020, certain holders of the 2025 Notes converted pursuant to the original terms of the 2025 Notes, an aggregate of approximately $13.5 million in principal amount of the 2025 Notes into 1,177,156 shares of the Company’s common stock, including 108,572 shares of common stock issued in satisfaction of the interest make-whole payment. In connection therewith, the Company recorded a loss of $1.2 million in the consolidated statement of operations.

The 2025 Notes are issued under an indenture, dated May 12, 2020 (the “Base Indenture”), between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”), as supplemented by the first supplemental indenture, dated May 12, 2020 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company and the Trustee.

The 2025 Notes will mature on May 1, 2025, unless earlier repurchased, redeemed or converted. The 2025 Notes are senior unsecured obligations of the Company and bear interest at an annual rate of 3.25%, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on November 1, 2020.

Holders of the 2025 Notes may convert the 2025 Notes into shares of the Company’s common stock (together with cash in lieu of any fractional share), at their option, at any time until the close of business on the scheduled trading day immediately before the maturity date. Upon conversion of the 2025 Notes, the Company will deliver for each $1,000 principal amount of 2025 Notes converted a number of shares of common stock (together with cash in lieu of any fractional share), equal to the conversion rate.

The initial conversion rate for the 2025 Notes is 79.2896 shares of common stock per $1,000 principal amount of 2025 Notes, which represents an initial conversion price of approximately $12.61 per share, and is subject to adjustment upon the occurrence of certain events, including, but not limited to, certain stock dividends, splits and combinations, the issuance of certain rights, options or warrants to holders of the common stock, certain distributions of assets, debt securities, capital stock or other property to holders of the common stock, cash dividends on the common stock and certain Company tender or exchange offers.

If a fundamental change (as defined in the Indenture) occurs at any time prior to the maturity date, then the noteholders may require the Company to repurchase their 2025 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. If a make-whole fundamental change (as defined in the Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time.

The 2025 Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after May 6, 2023 and on or before the scheduled trading day before the maturity date, at a cash redemption price equal to the principal amount of the 2025 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, as long as the last reported sale price per share of the common stock exceeds 130% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice.

The Indenture contains customary events of default. If an event of default (other than certain events of bankruptcy, insolvency or reorganization involving the Company) occurs and is continuing, the Trustee, by notice to the Company, or the holders of the 2025 Notes representing at least 25% in aggregate principal amount of the outstanding 2025 Notes, by notice to the Company and the Trustee, may declare 100% of the principal of, and all accrued and unpaid interest on, all of the then outstanding 2025 Notes to be due and payable immediately. Upon the occurrence of certain events of bankruptcy, insolvency or reorganization involving the Company, 100% of the principal of, and all accrued and unpaid interest on, all of the then outstanding 2025 Notes will automatically become immediately due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 360 days after such event of default, consist exclusively of the right to receive additional interest on the 2025 Notes.

Interest make-whole payment

The 2025 Notes also include an interest make-whole payment feature whereby if the last reported sale price of the Company’s common stock for each of the five trading days immediately preceding a conversion date is greater than or equal to $10.51, the Company will, in addition to the other consideration payable or deliverable in connection with such conversion, make an interest make-whole payment to the converting holder equal to the sum of the present values of the scheduled payments of interest that would have been made on the 2025 Notes to be converted had such notes remained outstanding from the conversion date through the earlier of (i) the date that is three years after the conversion date and (ii) the maturity date. The present values will be computed using a discount rate equal to 1%. The Company will satisfy its obligation to pay the interest make-whole payment, at its election, in cash or shares of common stock (together with cash in lieu of fractional shares). The Company has determined that this feature is an embedded derivative and has recognized the fair value of this derivative as a liability in the consolidated balance sheets, with subsequent changes to fair value to be recorded at each reporting period on the consolidated statement of operations in other income, net.

As of December 31, 2020, $166.9 million in principal amount of the 2025 Notes were outstanding, $80.4 million of which was held by related parties. Assuming no repurchases or conversion of the 2025 Notes prior to May 1, 2025, the entire principal balance of $166.9 million of the 2025 Notes, is due on May 1, 2025.

The 2025 Notes consist of the following (in thousands):


	December 31, 2020
Liability component
Principal	$	166,898
Add: fair value of embedded derivative	4,898
Less: unamortized debt discount	(3,703)
Less: unamortized issuance costs	(2,946)
Net carrying amount	$	165,147

The effective interest rate on the liability component of the 2025 Notes was 4.10% for the twelve months ended December 31, 2020. The following table sets forth total interest expense recognized related to the 2025 Notes (in thousands):


	Year Ended December 31, 2020

Contractual interest expense		$	3,434
Amortization of debt discount		552
Amortization of debt issuance costs		439
Total interest expense		$	4,425

As the offering of the 2025 Notes took place during the twelve months ended December 31, 2020, there was no interest expense in the comparable twelve months of 2019.

Subsequent to December 31, 2020, $5.0 million of the 2025 Notes were converted into 428,669 shares, pursuant to original terms of the 2025 Notes, including 32,221 shares of common stock in satisfaction of the interest-make-whole payments.

2022 Notes

On January 9, 2017, in connection with the Note Exchange (as defined below), the Company issued approximately $119.8 million aggregate principal amount of 2022 Notes.

During the three months ended March 31, 2020, the Company entered into privately-negotiated exchange agreements with certain investors holding the 2022 Notes. Pursuant to those exchange agreements, the investors exchanged $59.9 million in aggregate principal amount of outstanding 2022 Notes for 13,688,876 shares of common stock. The investors that participated in such exchange agreements agreed to waive any accrued but unpaid interest on the exchanged 2022 Notes. Included in the 13,688,876 shares of common stock issued in the exchange transactions that took place during the three months ended March 31, 2020 were 942,706 shares valued at $7.9 million on the date of issuance at fair value, which were issued pursuant to the terms of the privately-negotiated exchange agreements and were in excess of the consideration issuable under the original conversion terms of the exchanged 2022 Notes. ASC 470, Debt, requires the recognition through earnings of an inducement charge equal to the fair value of the consideration delivered in excess of the consideration issuable under the original conversion terms. This resulted in a non-cash charge of $7.9 million, which was recorded as inducement expense within loss on debt conversion and extinguishment, net, in the consolidated statement of operations.

Pursuant to the Private Exchange Transactions described above, on May 12, 2020, the holders of an aggregate of $45.0 million principal amount of 2022 Notes exchanged their 2022 Notes for a combination of 2025 Notes and cash. As a result of the Private Exchange Transactions, $2,000 in principal amount of the 2022 Notes were outstanding as of June 30, 2020. On July 22, 2020, pursuant to a redemption notice issued on May 15, 2020, the Company redeemed the remaining $2,000 principal amount of the 2022 Notes.

The 2022 Notes consist of the following (in thousands):


	December 31, 2019
Liability component
Principal	$	105,125
Less: unamortized debt discount and issuance costs	(3,791)
Net carrying amount	$	101,334

The effective interest rate on the liability component of the 2022 Notes was 12.89% for the twelve months ended December 31, 2020. The following table sets forth total interest expense recognized related to the 2022 Notes (in thousands):


	Year Ended December 31,
	2020		2019
Contractual interest expense	$	768	$	5,782
Amortization of debt discount	1,952		7,821
Amortization of debt issuance costs	111		459
Total interest expense	$	2,831	$	14,062

Novatel Wireless Notes

On June 10, 2015, Novatel Wireless issued $120.0 million of 5.50% convertible senior notes due 2020 (the “Novatel Wireless Notes”). The Company incurred issuance costs of approximately $3.9 million, which were governed by the terms of an indenture, dated June 10, 2015, between Novatel Wireless, as issuer, Inseego and Wilmington Trust, National Association, as trustee, as amended by certain supplemental indentures (“the Novatel Indenture”). On January 9, 2017, in connection with the settlement of an exchange offer and consent solicitation with respect to the Novatel Wireless Notes (the “Note Exchange”), approximately $119.8 million aggregate principal amount of outstanding Novatel Wireless Notes were validly tendered and accepted for exchange and subsequently canceled. In February 2020, the holders of the remaining $250,000 of the aggregate

principal amount of Novatel Wireless Notes that remained outstanding following the Note Exchange, converted their Novatel

Wireless Notes into 50,000 shares of Inseego Corp. common stock, at the conversion price of $5.00 per share, in accordance

with the terms of the Novatel Indenture. Accordingly, no Novatel Wireless Notes were outstanding as of December 31, 2020.

Income Taxes

12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

The Company’s loss before income taxes for the years ended December 31, 2020 and 2019 is comprised of the following (in thousands):


	Year Ended December 31,
	2020		2019
Domestic	$	(109,837)	$	(39,187)
Foreign	(601)		(387)
Loss before income taxes	$	(110,438)	$	(39,574)

The provision for income taxes for the years ended December 31, 2020 and 2019 is comprised of the following (in thousands):


	Year Ended December 31,
	2020		2019
Current:
Federal	$	—	$	(49)
State	(4)		35
Foreign	93		1,148
Total current	89		1,134
Deferred:
Federal	12		12
State	—		—
Foreign	647		(610)
Total deferred	659		(598)
Provision for income taxes	$	748	$	536

The Company’s net deferred tax liabilities consist of the following (in thousands):


	December 31,
	2020		2019
Deferred tax assets:
Accrued expenses	$	1,940	$	647
Provision for excess and obsolete inventory	2,016		2,003

Convertible debt	13,367		—
Interest expense limitation	7,798		5,562
Net operating loss and tax credit carryforwards	108,340		95,258
Share-based compensation	1,911		1,226
Right-of-use-asset	2,059		650
Unrecognized tax benefits	1,567		1,288
Deferred tax assets	138,998		106,634
Deferred tax liabilities:
Operating lease liability	(2,059)		(650)
Acquired intangible assets	(2,155)		(3,623)
Convertible debt	—		(866)
Depreciation and amortization	(5,545)		(1,742)
Unrealized foreign currency gains	(375)		—
Deferred tax liabilities	(10,134)		(6,881)
Valuation allowance	(133,369)		(103,702)
Net deferred tax liabilities	$	(4,505)	$	(3,949)

The Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable to or refundable by tax authorities in the current fiscal year. The Company also recognizes federal, state and foreign deferred tax liabilities or assets based on the Company’s estimate of future tax effects attributable to temporary differences and carryforwards. The Company records a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.

The Company assesses whether a valuation allowance should be recorded against its deferred tax assets based on the consideration of all available evidence, using a “more likely than not” realization standard. The four sources of taxable income that must be considered in determining whether deferred tax assets will be realized are: (1) future reversals of existing taxable temporary differences (i.e., offset of gross deferred tax assets against gross deferred tax liabilities); (2) taxable income in prior

carryback years, if carryback is permitted under the applicable tax law; (3) tax planning strategies; and (4) future taxable income exclusive of reversing temporary differences and carryforwards.

At December 31, 2020 and 2019, the Company recognized valuation allowances of $26.4 million and $9.2 million, respectively, related to its deferred tax assets created in those respective years. As a result, no net income tax benefits resulted in the Company’s statements of operations from the operating losses created during those years.

The provision for income taxes reconciles to the amount computed by applying the statutory federal income tax rate of 21% in 2020 and 2019 to loss before income taxes as follows (in thousands):


	Year Ended December 31,
	2020		2019
Federal tax benefit, at statutory rate	$	(23,192)	$	(8,311)
State benefit, net of federal benefit	(1,285)		27
Foreign tax rate difference	(140)		476


Valuation allowance against future tax benefits	26,410		9,168
Loss on conversion of debt	2,015		—




Research and development credits	(2,355)		(1,456)
Share-based compensation	(1,134)		341




Other, including true-up of prior year provisions	429		291
Provision for income taxes	$	748	$	536

At December 31, 2020, the Company had U.S. federal net operating loss carryforwards (“NOLs”) related to tax years 2020 and prior of approximately $429.3 million. Approximately $81.5 million of these NOLs have no expiration date. The remainder begin to expire in 2021, unless previously utilized. Some of these NOLs may be limited by either past or future changes in control events. The Company has California net operating loss carryforwards at December 31, 2020 of approximately $55.0 million, which begin to expire in 2028, unless previously utilized, and foreign net operating losses for its active foreign subsidiaries of approximately $46.7 million, which generally have no expiration date. At December 31, 2020, the Company had federal research and development tax credit carryforwards of approximately $12.8 million, which begin to expire in 2026, unless previously utilized, and California research and development tax credit carryforwards of approximately $14.0 million, which have no expiration date.

Pursuant to Internal Revenue Code (“IRC”) Sections 382 and 383, annual use of the Company’s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a rolling three-year period. An analysis was performed for the period through December 31, 2020 and did not identify any events of cumulative change in ownership during the review period. The Company will continue monitoring any future changes in stock ownership.

It is the Company’s intention to reinvest undistributed earnings of its foreign subsidiaries and thereby indefinitely postpone their remittance. Accordingly, no provision has been made for foreign withholding taxes on U.S. income taxes which may become payable if undistributed earnings of the foreign subsidiary were paid as dividends to the Company.

On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which includes modifications to the limitation on business interest expense and net operating loss provisions, and provides a payment delay of employer payroll taxes during 2020 after the date of enactment. Payments of approximately $1.4 million of employer payroll taxes otherwise due in 2020, were delayed with 50% due by December 31, 2021 and the remaining 50% by December 31, 2022. The CARES Act did not have a material impact on the Company’s consolidated financial statements.

The Company follows the accounting guidance related to financial statement recognition, measurement and disclosure of uncertain tax positions. The Company recognizes the impact of an uncertain income tax position on an income tax return at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. No income tax benefit was recognized during the years ended December 31, 2020 and 2019. At December 31, 2020 and 2019, the Company did not have interest expense related to uncertain tax positions or a liability for unrecognized tax benefits. The Company does not expect changes to its uncertain tax position in the next twelve months.

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):





Balance at December 31, 2018	$	36,906
Increases related to current and prior year tax positions	929

Balance at December 31, 2019	37,835
Increases related to current and prior year tax positions	1,796

Balance at December 31, 2020	$	39,631

There are no tax benefits that, if recognized, would affect the effective tax rate that are included in the balances of unrecognized tax benefits at December 31, 2020.

The Company and its subsidiaries file U.S., state and foreign income tax returns in jurisdictions with various statutes of limitations. The Company’s tax returns are subject to examination by federal, state and foreign taxing authorities. The Company’s federal and state tax returns are subject to examination for the years beginning in 2016 and 2015, respectively. Net operating loss carryforwards arising prior to these years are also open to examination, if and when utilized. The Company believes appropriate provisions for all outstanding issues have been made for all jurisdictions and all open years. However, because audit outcomes and the timing of audit settlements are subject to significant uncertainty, the Company’s current estimate of the total amounts of unrecognized tax benefits could increase or decrease for all open years.

Stockholders' Equity

12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

On August 6, 2018, the Company completed a private placement of 12,062,000 shares of its common stock and warrants (the “2018 Warrants”) to purchase an additional 4,221,700 shares of its common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions, to certain accredited investors for gross proceeds of $19.7 million in cash. Each warrant had an initial exercise price of $2.52 per share, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions.

On March 28, 2019, the 2018 Warrants were exercised at an exercise price of $2.52 per share, for aggregate cash proceeds to the Company of approximately $10.6 million. In connection with the exercise of the 2018 Warrants, on March 28, 2019, the Company issued additional warrants to purchase 2,500,000 shares of common stock (the “2019 Warrants”) to the accredited investors. Each 2019 Warrant has an initial exercise price of $7.00 per share, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions, will be exercisable at any time on or after September 28, 2019, and will expire on June 30, 2022. The 2019 Warrants may be exercisable on a cashless exercise basis if, and only if, the shares of common stock underlying such warrants cannot be immediately resold pursuant to an effective registration statement or Rule 144 of the Securities Act of 1933, as amended, without volume or manner of sale restrictions.

During the fourth quarter of 2019, the Company received $6.9 million in net cash proceeds from the exercise of 1,255,129 of the Company’s common stock purchase warrants issued in 2015.

The Company assessed the terms of the warrants under ASC 815, Derivatives and Hedging. Pursuant to this guidance, the Company has determined that the warrants do not require liability accounting and has classified the warrants as equity.

Preferred Stock

The Company has a total of 2,000,000 shares of preferred stock authorized for issuance at a par value of $0.001 per share, 150,000 of which have been designated Series D Preferred Stock and 39,500 of which have been designated Series E Preferred Stock.

On August 9, 2019, the Company completed a private placement of 10,000 shares of Series E Preferred Stock for an aggregate purchase price of $10.0 million in accordance with the terms and provisions of a Securities Purchase Agreement, dated August 9, 2019, by and among the Company and certain accredited investors. Each share of Series E Preferred Stock entitles the holder thereof to receive, when, as and if declared by the Company out of assets legally available therefor, cumulative cash dividends at an annual rate of 9.00% payable quarterly in arrears on January 1, April 1, July 1 and October 1 of each year, beginning on October 1, 2019. If dividends are not declared and paid in any quarter, or if such dividends are declared but holders of the Series E Preferred Stock elect not to receive them in cash, the quarterly dividend will be deemed to accrue and will be added to the Series E Base Amount. The Series E Preferred Stock has no voting rights unless otherwise required by law. The Series E Preferred Stock is perpetual and has no maturity date. However, the Company may, at its option, redeem shares of the Series E Preferred Stock, in whole or in part, on or after July 1, 2022, at a price equal to 110% of the Series E Base Amount plus (without duplication) any accrued and unpaid dividends. The “Series E Base Amount” means $1,000 per share,

plus any accrued but unpaid dividends, whether or not declared by the Company’s board of directors, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series E Preferred Stock. In the event of a liquidation, dissolution or winding up of the Company, the holders of the Series E Preferred Stock will be entitled to receive, after satisfaction of liabilities to creditors and subject to the rights of holders of any senior securities, but before any distribution of assets is made to holders of common stock or any other junior securities, the Series E Base Amount plus (without duplication) any accrued and unpaid dividends.

On March 6, 2020, the Company entered into a Securities Purchase Agreement with an accredited investor pursuant to which, among other things, the Company issued and sold to the investor, in a private placement transaction, an aggregate of 25,000 shares of the Company’s Series E Preferred Stock, for a purchase price of $1,000 per share of Series E Preferred Stock, resulting in gross proceeds to the Company of $25.0 million.

There were no dividends declared and $2.9 million and $0.4 million of dividends were accrued as of December 31, 2020, and 2019, respectively.

Rights Agreement

On January 22, 2018, the Company entered into a Rights Agreement with Computershare Trust Company, N.A., a federally chartered trust company, as rights agent (as subsequently amended, the “Rights Agreement”) and issued a dividend of one preferred share purchase right (a “Right”) to each of the stockholders of record of each share of common stock outstanding on February 2, 2018. Each Right entitled the registered holder to purchase from the Company one one-thousandth of a share of Series D Preferred Stock, par value $0.001 per share (the “Preferred Shares”), of the Company, at a price of $10.00 per one one-thousandth of a Preferred Share represented by a Right (the “Purchase Price”), subject to adjustment. The description and terms of the Rights are set forth in the Rights Agreement.

The Rights were not exercisable until the Distribution Date (as defined in the Rights Agreement). The Rights expired on January 22, 2021.

In connection with the issuance of the 2019 Warrants, on March 28, 2019, the Company entered into an Amendment No. 3 to the Rights Agreement, dated January 22, 2018, as amended by that certain Amendment No. 1 to Rights Agreement, dated August 6, 2018, and as amended by that certain Amendment No. 2 to Rights Agreement, dated December 4, 2018, between the Company and Computershare Trust Company, N.A., as rights agent, for the purpose of modifying the definition of “Acquiring Person” under the Rights Agreement to permit each of the Investors to remain a Grandfathered Stockholder (as defined in the Rights Agreement) and not be deemed an “Acquiring Person” under the Rights Agreement in connection with the Investors’ purchase of the 2019 Warrants.

The Investors will remain Grandfathered Stockholders under the terms of the Rights Agreement as long as they do not acquire, after the date of the Third Amendment to Rights Agreement, beneficial ownership of Company securities (other than as a result of any adjustment provision or the accrual of interest under any outstanding convertible notes) equal to more than 0.50% of the then-outstanding common stock. The Rights expired on January 22, 2021.

Common Shares Reserved for Future Issuance

The Company had reserved shares of common stock for possible future issuance as of December 31, 2020 and 2019 as follows:


	December 31,
	2020	2019
Common stock warrants outstanding	2,500,000	2,838,454
Stock options outstanding	8,479,979	9,044,304
Restricted stock units outstanding	417,105	400,315
Shares available for issuance pursuant to Convertible Notes	15,879,948	40,649,225

Shares available for future grants of awards under the 2018 Omnibus Incentive Compensation Plan	2,849,488	2,488,221
Shares available under the 2000 Employee Stock Purchase Plan	391,201	622,476
Total shares of common stock reserved for issuance	30,517,721	56,042,995

Share-based Compensation

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Share-based Compensation

During the year ended December 31, 2020, the Company granted awards under the 2018 Omnibus Incentive Compensation Plan, previously named the Amended and Restated 2009 Omnibus Incentive Compensation Plan (the “2018 Plan”), and the 2015 Incentive Compensation Plan (the “2015 Plan”). The Compensation Committee of the Board of Directors administers the plans.

During the year ended December 31, 2019, the Board approved and transferred all available shares from the 2015 Plan to the 2018 Plan. Under the 2018 Plan, a maximum of 8,897,084 shares of common stock may be issued upon the exercise of stock options, in the form of restricted stock, or in settlement of RSUs or other awards, including awards with alternative vesting schedules such as performance-based criteria.

For the years ended December 31, 2020 and 2019, the following table presents total share-based compensation expense in each functional line item on the consolidated statements of operations (in thousands):


	Year Ended December 31,
	2020		2019
Cost of revenues	$	1,583	$	1,133
Research and development	2,823		1,548
Sales and marketing	2,346		1,669
General and administrative	3,667		2,952

Total	$	10,419	$	7,302

Stock Options

The Compensation Committee of the Board of Directors determines eligibility, vesting schedules and exercise prices for stock options granted. Stock options generally have a term of ten years and vest over a three- to four-year period.

The following table presents the weighted-average assumptions used in the Black-Scholes valuation model by the Company in calculating the fair value of each stock option granted:


	Year Ended December 31,
	2020		2019
Expected dividend yield	—	%	—	%
Risk-free interest rate	0.9	%	1.8	%
Volatility	95	%	81	%
Expected term (in years)	5.8		5.8

The weighted-average fair value of stock option awards granted during the years ended December 31, 2020 and 2019 was $7.11 and $3.56, respectively.

The following table summarizes the Company’s stock option activity for the years ended December 31, 2020 and 2019 (dollars in thousands, except per share data):


	Stock Options Outstanding	Weighted-Average Exercise Price Per Option		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value




Outstanding — December 31, 2019	9,044,304	$	2.91
Granted	1,526,000	9.41
Exercised	(1,357,620)	3.06
Canceled	(732,705)	3.60
Outstanding — December 31, 2020	8,479,979	$	3.99	7.47	$	97,315
Vested and Expected to Vest — December 31, 2020	7,667,800	$	3.71	7.34	$	90,150
Exercisable — December 31, 2020	4,293,975	$	2.10	6.41	$	57,398

During the year ended December 31, 2019, 1,489,067 shares were issued upon the exercise of stock options. The total intrinsic value of stock options exercised to purchase common stock during the years ended December 31, 2020 and 2019 was approximately $11.7 million and $5.6 million, respectively.

As of December 31, 2020, total unrecognized share-based compensation expense related to non-vested stock options was $12.3 million, which is expected to be recognized over a weighted-average period of approximately 2.5 years. The Company recognized approximately $5.8 million and $3.5 million of share-based compensation expense related to the vesting of stock option awards during the years ended December 31, 2020 and 2019, respectively.

Restricted Stock Units

Pursuant to the 2018 Plan and the 2015 Plan, the Company may issue RSUs that, upon satisfaction of vesting conditions, allow recipients to receive common stock. Issuances of such awards reduce common stock available under the 2018 Plan and 2015 Plan for stock incentive awards. The Company measures compensation cost associated with grants of RSUs at fair value, which is generally the closing price of the Company’s stock on the date of grant. RSUs generally vest over a three- to four-year period.

A summary of restricted stock unit activity under all plans for the year ended December 31, 2020 is presented below:


	Number of Shares	Weighted-Average Grant-Date Fair Value
Non-vested — December 31, 2019	400,315	$	3.95
Granted	570,368	10.52
Vested	(548,160)	7.28
Forfeited	(5,418)	4.06
Non-vested — December 31, 2020	417,105	$	8.68

During the year ended December 31, 2019, the weighted-average grant-date fair value of RSUs granted was $5.07. During the years ended December 31, 2020 and 2019, the total fair value of shares vested was $5.1 million and $4.0 million, respectively.

As of December 31, 2020, there was $1.8 million of unrecognized share-based compensation expense related to non-vested RSUs, which is expected to be recognized over a weighted-average period of 2.2 years. The Company recognized approximately $4.1 million and $3.5 million of share-based compensation expense related to the vesting of RSUs during the years ended December 31, 2020 and 2019, respectively.

2000 Employee Stock Purchase Plan

The ESPP permits eligible employees of the Company to purchase newly issued shares of common stock, at a price equal to 85% of the lower of the fair market value on (i) the first day of the offering period or (ii) the last day of each six-month purchase period, through payroll deductions of up to 10% of their annual cash compensation. Under the ESPP, a maximum of 5,324,000 shares of common stock may be purchased by eligible employees.

During the years ended December 31, 2020 and 2019, the Company issued 231,275 shares and 203,061 shares, respectively, under the ESPP. The Company recognized approximately $0.6 million and $0.3 million of share-based compensation expense related to the ESPP during the years ended December 31, 2020 and 2019, respectively.

Earnings per Share

12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Earnings per Share

Earnings per ShareBasic EPS excludes dilution and is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock using the treasury stock method. Potentially dilutive securities (consisting primarily of the Convertible Notes calculated using the if-converted and treasury stock method and warrants, stock options and RSUs calculated using the treasury stock method) are excluded from the diluted EPS computation in loss periods and when the applicable exercise price is greater than the market price on the period end date as their effect would be anti-dilutive.

The calculation of basic and diluted earnings per share was as follows (in thousands, except share and per share data):


	Year Ended December 31,
	2020		2019
Net loss attributable to common stockholders	$	(114,119)	$	(40,486)
Weighted-average common shares outstanding	96,111,547		78,322,496
Basic and diluted net loss per share	$	(1.19)	$	(0.52)

For the year ended December 31, 2020, the computation of diluted EPS excluded 26,180,766 shares, primarily related to Convertible Notes, warrants, stock options and RSUs for which the effect would have been anti-dilutive.

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal The Company is, from time to time, party to various legal proceedings arising in the ordinary course of business. The Company is regularly required to directly or indirectly participate in other U.S. patent infringement actions pursuant to its contractual indemnification obligations to certain customers. Based on an evaluation of these matters and discussions with the Company’s intellectual property litigation counsel, the Company currently believes that liabilities arising from or sums paid in settlement of these existing matters, if any, would not have a material adverse effect on its consolidated results of operations or financial condition. On May 11, 2017, the Company initiated a lawsuit against the former stockholders of R.E.R. Enterprises, Inc. (“RER”) in the Court of Chancery of the State of Delaware seeking recovery of damages for civil conspiracy, fraud in the inducement, unjust enrichment and breach of fiduciary duty. On January 16, 2018, the former stockholders of RER filed an answer and counterclaim in the matter seeking recovery of certain deferred and earn-out payments allegedly owed to them by the Company in connection with the Company’s acquisition of RER. On July 26, 2018, the Company and the former stockholders of RER entered into a mutual general release and settlement agreement (the “Settlement Agreement”) pursuant to which the parties agreed to release all claims against each other and the Company agreed to (i) pay the former stockholders of RER $1.0 million in cash by August 17, 2018, (ii) immediately instruct its transfer agent to permit the transfer or sale of 973,333 shares of the Company’s common stock that the Company had issued to the former stockholders of RER in March 2017, (iii) immediately issue 500,000 shares of the Company’s common stock to the former stockholders of RER, (iv) within 12 months following the execution of the Settlement Agreement, deliver to the former stockholders of RER an additional $1.0 million in cash, common stock, or a combination thereof, at the Company’s option, (v) within 24 months following the execution of the Settlement Agreement deliver to the former stockholders of RER an additional $1.0 million in cash, common stock, or a combination thereof, at the Company’s option, and (vi) file one or more registration statements with respect to the resale of the shares of the Company’s common stock issued to the former stockholders of RER pursuant to the Settlement Agreement. On July 24, 2020, the Company issued 89,928 shares of common stock to the former stockholders of RER in satisfaction of all remaining liabilities under the Settlement Agreement. Indemnification In the normal course of business, the Company periodically enters into agreements that require the Company to indemnify and defend its customers for, among other things, claims alleging that the Company’s products infringe third-party patents or other intellectual property rights. The Company’s maximum exposure under these indemnification provisions cannot be estimated but the Company does not believe that there are any matters individually or collectively that would have a material adverse effect on its consolidated results of operations or financial condition.

Leases

12 Months Ended

Dec. 31, 2020

Leases [Abstract]

Leases

Lessee

The Company is a lessee in lease agreements for office space, automobiles and certain equipment. Certain of the Company’s leases contain provisions that provide for one or more options to renew at the Company’s sole discretion. The majority of the Company’s leases are comprised of fixed lease payments, with a small percentage of its real estate leases including lease payments subject to a rate or index which may be variable. Certain real estate leases also include executory costs such as common area maintenance (non-lease component). As a practical expedient permitted under ASC 842, the Company has elected to account for the lease and non-lease components as a single lease component. Lease payments, which may include lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to

the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract.

None of the Company’s lease agreements contain any material residual value guarantees or material restrictive covenants. As a result of the Company’s election of the package of practical expedients permitted within ASC 842, which among other things, allows for the carryforward of historical lease classification, all of the Company’s lease agreements in existence at the date of adoption that were classified as operating leases under ASC 840, Leases have been classified as operating leases under ASC 842. Lease expense for payments related to the Company’s operating leases is recognized on a straight-line basis over the related lease term, which includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

Right-of-use assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments as specified in the lease. Right-of-use assets and lease liabilities related to the Company’s operating leases are recognized at the lease commencement date based on the present value of the remaining lease payments over the lease term. When the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the lease term and the information available surrounding the Company’s borrowing rates at the lease commencement date in determining the present value of lease payments. The right-of-use asset also includes any lease payments made at or before lease commencement less any lease incentives. As of December 31, 2020, the Company had right-of-use assets of $9.1 million and lease liabilities related to its operating leases of $9.9 million. Right-of-use assets are included in right-of-use assets, net, on the consolidated balance sheet and lease liabilities related to the Company’s operating leases are included in accrued expenses and other liabilities and other long-term liabilities on the consolidated balance sheet. As of December 31, 2020, the Company’s weighted-average remaining lease term and weighted-average discount rate related to its operating leases were 5.8 years and 9.1%, respectively.

During the years ended December 31, 2020 and 2019, the cash paid for amounts included in the measurement of lease liabilities related to the Company’s operating leases was approximately $1.9 million and $2.2 million, respectively, which is included as an operating cash outflow within the consolidated statements of cash flows. During the twelve months ended December 31, 2020 and 2019, the operating lease costs related to the Company’s operating leases were approximately $2.2 million and $2.4 million, respectively, which is included in operating costs and expenses in the consolidated statements of operations. During the twelve months ended December 31, 2020, the Company entered into a lease agreement for its new corporate offices and renewed the lease on a research and development facility for which right-of-use assets were recorded in exchange for new lease liabilities.

The future minimum payments under operating leases were as follows at December 31, 2020 (in thousands):



2021	$	2,460
2022	2,225
2023	1,916
2024	1,787
2025	1,630
Thereafter	2,807
Total minimum operating lease payments	12,825
Less: amounts representing interest	(2,921)
Present value of net minimum operating lease payments	9,904
Less: current portion	(1,619)
Long-term portion of operating lease obligations	$	8,285

Lessor

Monitoring device leases in which the Company serves as lessor are classified as operating leases. Accordingly, rental devices are carried at historical cost less accumulated depreciation and impairment, if any, and are included in rental assets, net, on the consolidated balance sheets.

Since the lease components meet the criteria for an operating lease under ASC 842, the Company has elected the practical expedient to combine the lease and the non-lease components because the service is the predominant element in the eyes of the customer and the pattern of service delivery is the same for both elements. The Company will account for the combined component as a single performance obligation under ASC 606, Revenue from Contracts with Customers.

Leases

Lessee

the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract.

The future minimum payments under operating leases were as follows at December 31, 2020 (in thousands):



2021	$	2,460
2022	2,225
2023	1,916
2024	1,787
2025	1,630
Thereafter	2,807
Total minimum operating lease payments	12,825
Less: amounts representing interest	(2,921)
Present value of net minimum operating lease payments	9,904
Less: current portion	(1,619)
Long-term portion of operating lease obligations	$	8,285

Lessor

Geographic Information and Concentrations of Risk

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Geographic Information and Concentrations of Risk

Geographic Information

The following table details the geographic concentration of the Company’s assets (in thousands):


	December 31,
	2020		2019
United States and Canada	$	148,485	$	81,769
South Africa	48,211		53,610


Other	30,698		25,994
	$	227,394	$	161,373

The following table details the Company’s net revenues by geographic region based on shipping destination (in thousands):


	Year Ended December 31,
	2020		2019
United States and Canada	$	260,009	$	158,756
South Africa	28,208		35,001
Other	25,615		25,739
Total	$	313,832	$	219,496

Concentrations of Risk

For the years ended December 31, 2020 and 2019, one customer accounted for 54.5% and 52.5% of net revenues, respectively. At December 31, 2020, two customers accounted for 33.3% and 17.2% of total accounts receivable. At December 31, 2019, two customers accounted for 25.0% and 11.2% of total accounts receivable.

During the years ended December 31, 2020 and 2019, the Company recorded net foreign currency transaction losses of approximately $0.7 million and $0.3 million, respectively, primarily related to outstanding intercompany loans that Ctrack has with certain of its subsidiaries, which are remeasured at each reporting period and payable upon demand.

All recorded gains and losses on foreign currency transactions are recorded in other income (expense), net, in the consolidated statements of operations.

Retirement Savings Plan	12 Months Ended
Retirement Savings Plan	Dec. 31, 2020
Retirement Benefits [Abstract]
Retirement Savings Plan	Retirement Savings PlanThe Company has a defined contribution 401(k) retirement savings plan (the “Plan”). Substantially all of the Company’s U.S. employees are eligible to participate in the Plan after meeting certain minimum age and service requirements. The Company matches 50% of the first 6% of an employee’s designated deferral of their eligible compensation. Employees may make discretionary contributions to the Plan subject to Internal Revenue Service limitations. Employer matching contributions under the Plan amounted to approximately $0.7 million and $0.4 million for the years ended December 31, 2020 and 2019, respectively. Employer matching contributions vest immediately.

Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (Unaudited)

The following is a summary of unaudited quarterly results of operations for the years ended December 31, 2020 and 2019:


	2020
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter

	(in thousands, except per share amounts)
Net revenues	$	56,840	$	80,689	$	90,240	$	86,063
Gross profit	17,227		22,000		25,170		26,447
Net loss attributable to common stockholders	(18,590)		(75,665)		(6,271)		(13,593)
Basic and diluted net loss per share	(0.20)		(0.78)		(0.06)		(0.14)


	2019
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter

	(in thousands, except per share amounts)
Net revenues	$	48,556	$	55,891	$	62,716	$	52,333
Gross profit	14,760		15,555		18,625		15,031
Net loss attributable to stockholders	(7,485)		(10,779)		(8,937)		(13,285)
Basic and diluted net income (loss) per share	(0.10)		(0.14)		(0.11)		(0.17)

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events At-the-Market Offering On January 25, 2021, the Company entered into an Equity Distribution Agreement with Canaccord Genuity LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, up to $40.0 million of shares of its common stock (the “ATM Offering”) pursuant to the Company’s Registration Statement on Form S-3ASR (File No. 333-238057), which was filed with the Securities and Exchange Commission on May 7, 2020, and the 424(b) prospectus supplement relating to the Offering dated January 25, 2021. In January 2021, the Company sold 1,516,073 shares of common stock, at a public offering price of $20.11 per share, for net proceeds of $29.6 million, pursuant to the ATM Offering. Sale of Ctrack South African Operations On February 24, 2021, the Company announced its entry into a Share Purchase Agreement with an affiliate of Convergence, to sell its South African operations, in an all-cash transaction for 528.9 million South African Rand (ZAR) (approximately $36.2 million United States Dollar (“USD”) based on an exchange rate on February 24, 2021 of 14.62 ZAR to 1 USD), subject to certain regulatory approvals and other closing conditions. The transaction is expected to close during the second quarter of fiscal 2021.

Nature of Business and Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Basis of Presentation

Additionally, the Company is uncertain of the full extent to which the COVID-19 pandemic will impact the Company’s business, operations and financial results.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent liabilities. Actual results could differ materially from these estimates. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the novel coronavirus pandemic ("COVID-19") could have on our significant accounting estimates. Significant estimates include revenue recognition, capitalized software costs, allowance for doubtful accounts receivable, provision for excess and obsolete inventory, valuation of intangible and long-lived assets, valuation of goodwill, valuation of derivatives, accruals relating to litigation, income taxes, and share-based compensation expense.

Segment Information

Segment InformationManagement has determined that the Company has one reportable segment. The Chief Executive Officer, who is also the Chief Operating Decision Maker, does not manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and operating results.

Cash and Cash Equivalents

Allowance for Doubtful Accounts Receivable

Inventories and Provision for Excess and Obsolete Inventory

Property, Plant and Equipment

Rental Assets

Research and development

Research and developmentResearch and development expense consists primarily of personnel costs for our engineers engaged in the design and development of our products, software and technologies, including salary, bonus and share‐based compensation expense, project material costs, services, depreciation and amortization. Such costs are charged to research and development expense as they are incurred, to the extent not capitalized as software development costs for external or internal use.

Software Development Costs

Software Development Costs for External Use

Software Development Costs for Internal Use

Intangible Assets

Long-Lived Assets

Long-Lived AssetsThe Company periodically evaluates the carrying value of the unamortized balances of its long-lived assets, including property, plant and equipment, rental assets and intangible assets, to determine whether impairment of these assets has occurred or whether a revision to the related amortization periods should be made. When the carrying value of an asset exceeds the associated undiscounted expected future cash flows, it is considered to be impaired and is written down to fair value. Fair value is determined based on an evaluation of the assets’ associated undiscounted future cash flows or appraised value. This evaluation is based on management’s projections of the undiscounted future cash flows associated with each class of asset. If management’s evaluation indicates that the carrying values of these assets are impaired, such impairment is recognized by a reduction of the applicable asset carrying value to its estimated fair value and the impairment is expensed as a part of continuing operations.

Convertible Debt Instruments

Derivative Financial Instruments

Revenue Recognition

Net revenues by product grouping for the years ended December 31, 2020 and 2019 were as follows (in thousands):


	Year Ended December 31,
	2020		2019
IoT & Mobile Solutions	$	261,169	$	160,873
Enterprise SaaS Solutions	52,663		58,623
Total	$	313,832	$	219,496

See geographic disaggregation information in Note 12, Geographic Information and Concentrations of Risk.

Contracts with Customers

The Company determines revenue recognition through the following five steps:

1)identification of the contract, or contracts, with a customer;

2)identification of the performance obligations in the contract;

3)determination of the transaction price;

4)allocation of the transaction price to the performance obligations in the contract; and

5)recognition of revenue when, or as, performance obligations are satisfied.

impact the transaction price. The Company does not offer price concessions and does not accept payment that is less than the price stated when it accepts the purchase order.

Revenue Recognition

Multiple Performance Obligations

Contract Liabilities

Contract Assets

Significant Judgments in the Application of the Guidance in ASC 606

Shipping and Handling Charges

Fees charged to customers for shipping and handling of products are included in product revenues, and costs for shipping and handling of products are included as a component of cost of sales.

Taxes Collected from Customers

Foreign Currency Transactions and Translation

Foreign Currency Transactions

Foreign Currency Translation

exchange rates during the period. The resulting translation adjustments are included in the Company’s consolidated balance sheets as a component of accumulated other comprehensive loss.

Income Taxes

Litigation

Share-Based Compensation

Compensation cost associated with grants of restricted stock units are measured at fair value, which has historically been the closing price of the Company’s common stock on the date of grant.

Net Loss Per Share Attributable to Inseego Corp.

Net Loss Per Share Attributable to Inseego Corp.The Company computes basic and diluted per share data for all periods for which a statement of operations is presented. Basic net loss per share excludes dilution and is computed by dividing the net loss by the weighted-average number of shares that were outstanding during the period. Diluted earnings per share (“EPS”) reflects the potential dilution that could occur if securities or other contracts to acquire common stock were exercised or converted into common stock. Potential dilutive securities are excluded from the diluted EPS computation in loss periods as their effect would be anti-dilutive.

Fair Value of Financial Instruments

Comprehensive Loss

Comprehensive loss consists of net earnings and foreign currency translation adjustments.

Prior Period Reclassifications

Certain amounts in prior periods have been reclassified to conform with current period presentation.

Recent Accounting Pronouncements

New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB, which are adopted by the Company as of the specified date.

Fair Value Measurement

Level 3: Pricing inputs include significant inputs that are generally less observable from objective sources, including the Company’s own assumptions.

Nature of Business and Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Schedule of Disaggregation of Revenue

Net revenues by product grouping for the years ended December 31, 2020 and 2019 were as follows (in thousands):


	Year Ended December 31,
	2020		2019
IoT & Mobile Solutions	$	261,169	$	160,873
Enterprise SaaS Solutions	52,663		58,623
Total	$	313,832	$	219,496

Financial Statement Details (Tables)

12 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Inventories

Inventories consist of the following (in thousands):


	December 31,
	2020		2019
Finished goods	$	27,009	$	21,229
Raw materials and components	6,943		4,061
	$	33,952	$	25,290

Summary of Property, Plant and Equipment and Rental Assets

Property, plant and equipment consists of the following (in thousands):


	December 31,
	2020		2019
Land	$	244	$	253
Buildings	2,213		2,303
Test equipment	16,775		10,952
Computer equipment and purchased software	7,899		6,911
Product tooling	3,125		2,139
Furniture and fixtures	1,310		1,535
Vehicles	2,988		2,535
Leasehold improvements	860		145
	35,414		26,773
Less—accumulated depreciation and amortization	(21,715)		(16,017)
	$	13,699	$	10,756

Rental assets consist of the following (in thousands):


	December 31,
	2020		2019
Rental assets	$	21,863	$	18,176
Less—accumulated depreciation	(15,754)		(12,791)
	$	6,109	$	5,385

Summary of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	December 31,
	2020		2019
Royalties	$	2,410	$	1,415
Payroll and related expenses	6,006		2,716


Professional fees	921		483

Accrued interest	888		1,543
Deferred revenue	2,853		2,235

Operating lease liabilities	1,619		1,101
Acquisition-related liabilities	—		1,000

Other	8,676		7,555
	$	23,373	$	18,048

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

A summary of the activity in goodwill is presented below (in thousands):


Balance at December 31, 2018	$	32,942




Effect of change in foreign currency exchange rates	717
Balance at December 31, 2019	33,659


Effect of change in foreign currency exchange rates	(1,148)
Balance at December 31, 2020	$	32,511

Schedule of Intangible Assets

The Company’s intangible assets are comprised of the following (in thousands):


	December 31, 2020
	Weighted-Average Life (in years)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Finite-lived intangible assets:
Developed technologies	6.0	$	12,692	$	(10,878)	$	1,814
Trademarks and trade names	10.0	17,823		(9,597)		8,226
Customer relationships	8.5	12,306		(8,703)		3,603
Capitalized software development costs	3.3	47,818		(31,051)		16,767
Other	2.5	3,389		(2,791)		598
Total finite-lived intangible assets		$	94,028	$	(63,020)	31,008
Indefinite-lived intangible assets:
In-process capitalized software development costs						20,479
Total intangible assets						$	51,487


	December 31, 2019
	Weighted-Average Life (in years)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Finite-lived intangible assets:
Developed technologies	6.0	$	13,076	$	(9,198)	$	3,878
Trademarks and trade names	10.0	18,352		(8,040)		10,312
Customer relationships	8.4	12,460		(7,413)		5,047
Capitalized software development costs	3.6	19,375		(6,570)		12,805
Other	2.4	2,986		(1,790)		1,196
Total finite-lived intangible assets		$	66,249	$	(33,011)	33,238
Indefinite-lived intangible assets:
In-process capitalized software development costs						11,154
Total intangible assets						$	44,392

Schedule of Amortization Expense of Finite-Lived Intangible Assets Expected to be Recognized

The following table represents details of the amortization of finite-lived intangible assets that is estimated to be expensed in the future (in thousands):


2021	13,026
2022	7,390
2023	4,383
2024	3,937
2025	2,272

Total	$	31,008

Fair Value Measurement of Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis


	Balance as of December 31, 2020		Level 1
Assets:
Cash equivalents
Money market funds	$	126	$	126

Total cash equivalents	$	126	$	126


	Balance as of December 31, 2019		Level 1
Assets:
Cash equivalents
Money market funds	$	126	$	126

Total cash equivalents	$	126	$	126


	Balance as of December 31, 2020		Level 3
Liabilities:
2025 Notes
Interest make-whole payment	$	4,898	$	4,898

Total embedded derivatives	$	4,898	$	4,898

Schedule of Fair Value Valuation Model and Assumptions

The fair value of the interest make-whole payment derivative liability was determined using a Monte Carlo model with the following key assumptions:


	May 12, 2020		December 31, 2020
Volatility	60	%	50	%
Stock price	$10.62 per share		$15.47 per share
Credit spread	14.97	%	19.25	%
Term	4.97 years		4.34 years
Dividend yield	—	%	—	%
Risk-free rate	0.34	%	0.30	%

Summary of Changes in Fair Value of Level 3 Liabilities

The following table sets forth a summary of changes in the fair value of Level 3 liabilities for the twelve months ended December 31, 2020 (in thousands):


	Balance as of December 31, 2019		Additions		Conversions		Change in fair value		Balance as of December 31, 2020
Liabilities:
Interest make-whole payment	$	—	$	4,582	$	(281)	$	597	$	4,898

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

Debt (Tables)

12 Months Ended

Dec. 31, 2020

Debt Disclosure [Abstract]

Schedule of Net Carrying Amount of Debt

The Term Loan consisted of the following (in thousands):


	December 31,
	2019
Principal	$	47,500
Less: unamortized debt discount and debt issuance costs	(962)
Net carrying amount	$	46,538

The 2025 Notes consist of the following (in thousands):


	December 31, 2020
Liability component
Principal	$	166,898
Add: fair value of embedded derivative	4,898
Less: unamortized debt discount	(3,703)
Less: unamortized issuance costs	(2,946)
Net carrying amount	$	165,147

The 2022 Notes consist of the following (in thousands):


	December 31, 2019
Liability component
Principal	$	105,125
Less: unamortized debt discount and issuance costs	(3,791)
Net carrying amount	$	101,334

Schedule of Interest Expense

The following table sets forth total interest expense recognized related to the Term Loan during the years ended December 31, 2020 and 2019 (in thousands):


	Year Ended December 31,
	2020		2019
Contractual interest expense	$	1,667	$	4,789
Amortization of debt discount	859		1,331
Amortization of debt issuance costs	103		161
Total interest expense	$	2,629	$	6,281

The following table sets forth total interest expense recognized related to the 2025 Notes (in thousands):


	Year Ended December 31, 2020

Contractual interest expense		$	3,434
Amortization of debt discount		552
Amortization of debt issuance costs		439
Total interest expense		$	4,425

The following table sets forth total interest expense recognized related to the 2022 Notes (in thousands):


	Year Ended December 31,
	2020		2019
Contractual interest expense	$	768	$	5,782
Amortization of debt discount	1,952		7,821
Amortization of debt issuance costs	111		459
Total interest expense	$	2,831	$	14,062

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Summary of Loss before Income Taxes

The Company’s loss before income taxes for the years ended December 31, 2020 and 2019 is comprised of the following (in thousands):


	Year Ended December 31,
	2020		2019
Domestic	$	(109,837)	$	(39,187)
Foreign	(601)		(387)
Loss before income taxes	$	(110,438)	$	(39,574)

Summary of Provision for Income Taxes

The provision for income taxes for the years ended December 31, 2020 and 2019 is comprised of the following (in thousands):


	Year Ended December 31,
	2020		2019
Current:
Federal	$	—	$	(49)
State	(4)		35
Foreign	93		1,148
Total current	89		1,134
Deferred:
Federal	12		12
State	—		—
Foreign	647		(610)
Total deferred	659		(598)
Provision for income taxes	$	748	$	536

Summary of Net Deferred Tax Assets

The Company’s net deferred tax liabilities consist of the following (in thousands):


	December 31,
	2020		2019
Deferred tax assets:
Accrued expenses	$	1,940	$	647
Provision for excess and obsolete inventory	2,016		2,003

Convertible debt	13,367		—
Interest expense limitation	7,798		5,562
Net operating loss and tax credit carryforwards	108,340		95,258
Share-based compensation	1,911		1,226
Right-of-use-asset	2,059		650
Unrecognized tax benefits	1,567		1,288
Deferred tax assets	138,998		106,634
Deferred tax liabilities:
Operating lease liability	(2,059)		(650)
Acquired intangible assets	(2,155)		(3,623)
Convertible debt	—		(866)
Depreciation and amortization	(5,545)		(1,742)
Unrealized foreign currency gains	(375)		—
Deferred tax liabilities	(10,134)		(6,881)
Valuation allowance	(133,369)		(103,702)
Net deferred tax liabilities	$	(4,505)	$	(3,949)

Summary of Provision for Income Taxes Reconciles to Amount Computed by Applying Statutory Federal Income Tax Rate

The provision for income taxes reconciles to the amount computed by applying the statutory federal income tax rate of 21% in 2020 and 2019 to loss before income taxes as follows (in thousands):


	Year Ended December 31,
	2020		2019
Federal tax benefit, at statutory rate	$	(23,192)	$	(8,311)
State benefit, net of federal benefit	(1,285)		27
Foreign tax rate difference	(140)		476


Valuation allowance against future tax benefits	26,410		9,168
Loss on conversion of debt	2,015		—




Research and development credits	(2,355)		(1,456)
Share-based compensation	(1,134)		341




Other, including true-up of prior year provisions	429		291
Provision for income taxes	$	748	$	536

Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):





Balance at December 31, 2018	$	36,906
Increases related to current and prior year tax positions	929

Balance at December 31, 2019	37,835
Increases related to current and prior year tax positions	1,796

Balance at December 31, 2020	$	39,631

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Summary of Common Shares Reserved for Future Issuance

The Company had reserved shares of common stock for possible future issuance as of December 31, 2020 and 2019 as follows:


	December 31,
	2020	2019
Common stock warrants outstanding	2,500,000	2,838,454
Stock options outstanding	8,479,979	9,044,304
Restricted stock units outstanding	417,105	400,315
Shares available for issuance pursuant to Convertible Notes	15,879,948	40,649,225

Shares available for future grants of awards under the 2018 Omnibus Incentive Compensation Plan	2,849,488	2,488,221
Shares available under the 2000 Employee Stock Purchase Plan	391,201	622,476
Total shares of common stock reserved for issuance	30,517,721	56,042,995

Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Summary of Share-Based Compensation Expense


	Year Ended December 31,
	2020		2019
Cost of revenues	$	1,583	$	1,133
Research and development	2,823		1,548
Sales and marketing	2,346		1,669
General and administrative	3,667		2,952

Total	$	10,419	$	7,302

Share-based Compensation Stock Option Fair Value Assumptions

The following table presents the weighted-average assumptions used in the Black-Scholes valuation model by the Company in calculating the fair value of each stock option granted:


	Year Ended December 31,
	2020		2019
Expected dividend yield	—	%	—	%
Risk-free interest rate	0.9	%	1.8	%
Volatility	95	%	81	%
Expected term (in years)	5.8		5.8

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the years ended December 31, 2020 and 2019 (dollars in thousands, except per share data):


	Stock Options Outstanding	Weighted-Average Exercise Price Per Option		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value




Outstanding — December 31, 2019	9,044,304	$	2.91
Granted	1,526,000	9.41
Exercised	(1,357,620)	3.06
Canceled	(732,705)	3.60
Outstanding — December 31, 2020	8,479,979	$	3.99	7.47	$	97,315
Vested and Expected to Vest — December 31, 2020	7,667,800	$	3.71	7.34	$	90,150
Exercisable — December 31, 2020	4,293,975	$	2.10	6.41	$	57,398

Summary of Restricted Stock Unit Activity

A summary of restricted stock unit activity under all plans for the year ended December 31, 2020 is presented below:


	Number of Shares	Weighted-Average Grant-Date Fair Value
Non-vested — December 31, 2019	400,315	$	3.95
Granted	570,368	10.52
Vested	(548,160)	7.28
Forfeited	(5,418)	4.06
Non-vested — December 31, 2020	417,105	$	8.68

Earnings per Share (Tables)

12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Schedule of Calculation of Basic and Diluted Earnings per Share

The calculation of basic and diluted earnings per share was as follows (in thousands, except share and per share data):


	Year Ended December 31,
	2020		2019
Net loss attributable to common stockholders	$	(114,119)	$	(40,486)
Weighted-average common shares outstanding	96,111,547		78,322,496
Basic and diluted net loss per share	$	(1.19)	$	(0.52)

Leases (Tables)

12 Months Ended

Dec. 31, 2020

Leases [Abstract]

Schedule of Future Minimum Payments Under Operating Leases

The future minimum payments under operating leases were as follows at December 31, 2020 (in thousands):



2021	$	2,460
2022	2,225
2023	1,916
2024	1,787
2025	1,630
Thereafter	2,807
Total minimum operating lease payments	12,825
Less: amounts representing interest	(2,921)
Present value of net minimum operating lease payments	9,904
Less: current portion	(1,619)
Long-term portion of operating lease obligations	$	8,285

Geographic Information and Concentrations of Risk (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Schedule of Geographic Concentration of Assets

The following table details the geographic concentration of the Company’s assets (in thousands):


	December 31,
	2020		2019
United States and Canada	$	148,485	$	81,769
South Africa	48,211		53,610


Other	30,698		25,994
	$	227,394	$	161,373

Schedule of Geographic Concentration of Net Revenues

The following table details the Company’s net revenues by geographic region based on shipping destination (in thousands):


	Year Ended December 31,
	2020		2019
United States and Canada	$	260,009	$	158,756
South Africa	28,208		35,001
Other	25,615		25,739
Total	$	313,832	$	219,496

Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Summary of Unaudited Quarterly Results of Operations

The following is a summary of unaudited quarterly results of operations for the years ended December 31, 2020 and 2019:


	2020
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter

	(in thousands, except per share amounts)
Net revenues	$	56,840	$	80,689	$	90,240	$	86,063
Gross profit	17,227		22,000		25,170		26,447
Net loss attributable to common stockholders	(18,590)		(75,665)		(6,271)		(13,593)
Basic and diluted net loss per share	(0.20)		(0.78)		(0.06)		(0.14)


	2019
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter

	(in thousands, except per share amounts)
Net revenues	$	48,556	$	55,891	$	62,716	$	52,333
Gross profit	14,760		15,555		18,625		15,031
Net loss attributable to stockholders	(7,485)		(10,779)		(8,937)		(13,285)
Basic and diluted net income (loss) per share	(0.10)		(0.14)		(0.11)		(0.17)

Nature of Business and Significant Accounting Policies - Narrative (Details)					1 Months Ended	2 Months Ended	3 Months Ended			12 Months Ended
	Jul. 22, 2020 USD ($)	May 12, 2020 USD ($)	Mar. 06, 2020 USD ($) $ / shares shares	Aug. 09, 2019 USD ($) shares	Jan. 31, 2021 USD ($) $ / shares shares	Mar. 01, 2021 USD ($) shares	Dec. 31, 2020 USD ($) $ / shares	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($) shares	Dec. 31, 2020 USD ($) Segments $ / shares shares	Dec. 31, 2019 USD ($) $ / shares
Nature Of Business And Significant Accounting Policies [Line Items]
Net loss attributable to Inseego Corp.										$ 111,215,000	$ 40,125,000
Cash and cash equivalents							$ 40,000,000.0			40,000,000.0
Working capital							$ 38,400,000			$ 38,400,000
Preferred stock, par value (in dollars per share) \| $ / shares							$ 0.001			$ 0.001	$ 0.001
Preferred stock issued during the period										$ 25,000,000	$ 10,000,000
2022 Notes conversion to equity										59,907,000	0
Gross proceeds from the issuance of 2025 Notes										100,000,000	0
Cash paid in exchange transaction		$ 32,000,000.0								$ 32,062,000	0
Number of reportable segments \| Segments										1
Impairment of capitalized software										$ 1,410,000	0
Impairment of indefinite-lived intangible assets										$ 0	$ 0
Minimum
Nature Of Business And Significant Accounting Policies [Line Items]
General warranty period										12 months
Maximum
Nature Of Business And Significant Accounting Policies [Line Items]
General warranty period										36 months
Buildings
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										50 years
Leasehold improvements \| Maximum
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										5 years
Product tooling
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										13 months
Computer equipment, purchased software, vehicles, production equipment, and furniture and fixtures \| Minimum
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										2 years
Computer equipment, purchased software, vehicles, production equipment, and furniture and fixtures \| Maximum
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										5 years
Rental assets \| Minimum
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										3 years
Rental assets \| Maximum
Nature Of Business And Significant Accounting Policies [Line Items]
Property, plant and equipment useful lives										4 years
Series E preferred shares
Nature Of Business And Significant Accounting Policies [Line Items]
Issuance of shares (in shares) \| shares			25,000	10,000
Preferred stock, par value (in dollars per share) \| $ / shares			$ 0.001				$ 0.001			$ 0.001	$ 0.001
Preferred stock issued during the period			$ 25,000,000.0	$ 10,000,000.0
Number of shares issued (in shares) \| shares			25,000
Purchase price (in dollars per share) \| $ / shares			$ 1,000
Subsequent event
Nature Of Business And Significant Accounting Policies [Line Items]
Number of shares issued (in shares) \| shares					1,516,073
Purchase price (in dollars per share) \| $ / shares					$ 20.11
Proceeds from sale of stock					$ 29,600,000
2025 Notes
Nature Of Business And Significant Accounting Policies [Line Items]
Debt conversion amount										$ 13,500,000
Conversion (shares) \| shares										1,177,156
Value of converted amount							$ 13,500,000			$ 13,500,000
2025 Notes \| Subsequent event
Nature Of Business And Significant Accounting Policies [Line Items]
Debt conversion amount						$ 5,000,000.0
Conversion (shares) \| shares						428,669
Convertible debt \| 2022 Notes
Nature Of Business And Significant Accounting Policies [Line Items]
2022 Notes conversion to equity								$ 59,900,000
Stated interest rate (percent)								5.5
Carrying amount of debt		$ 45,000,000.0						$ 2,000			$ 105,125,000
Debt conversion amount	$ 2,000								$ 59,900,000
Conversion (shares) \| shares									13,688,876
Convertible debt \| 2025 Notes
Nature Of Business And Significant Accounting Policies [Line Items]
Stated interest rate (percent)		3.25
Gross proceeds from the issuance of 2025 Notes		$ 100,000,000.0
Carrying amount of debt							$ 166,898,000			$ 166,898,000
Debt issued in exchange transaction		$ 80,400,000

Nature of Business and Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
IoT & Mobile Solutions									$ 261,169	$ 160,873
Enterprise SaaS Solutions									52,663	58,623
Total net revenues	$ 86,063	$ 90,240	$ 80,689	$ 56,840	$ 52,333	$ 62,716	$ 55,891	$ 48,556	$ 313,832	$ 219,496

Financial Statement Details - Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Finished goods	$ 27,009	$ 21,229
Raw materials and components	6,943	4,061
Total inventory	$ 33,952	$ 25,290

Financial Statement Details - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 35,414	$ 26,773
Less—accumulated depreciation and amortization	(21,715)	(16,017)
Property, plant and equipment, net	13,699	10,756
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	244	253
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,213	2,303
Test equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	16,775	10,952
Computer equipment and purchased software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	7,899	6,911
Product tooling
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	3,125	2,139
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,310	1,535
Vehicles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,988	2,535
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 860	$ 145

Financial Statement Details - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Vehicles and equipment under finance leases, net	$ 2.6	$ 2.1
Vehicles and equipment under finance leases, accumulated amortization	(1.0)	(2.6)
Depreciation and amortization expense	$ 10.0	$ 8.8

Financial Statement Details - Rental Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Rental assets	$ 21,863	$ 18,176
Less—accumulated depreciation	(15,754)	(12,791)
Rental assets, net	$ 6,109	$ 5,385

Financial Statement Details - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Royalties	$ 2,410	$ 1,415
Payroll and related expenses	6,006	2,716
Professional fees	921	483
Accrued interest	888	1,543
Deferred revenue	2,853	2,235
Operating lease liabilities	1,619	1,101
Acquisition-related liabilities	0	1,000
Other	8,676	7,555
Accrued expenses and other current liabilities, total	$ 23,373	$ 18,048

Goodwill and Other Intangible Assets - Goodwill Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill [Roll Forward]
Balance at beginning of period	$ 33,659	$ 32,942
Effect of change in foreign currency exchange rates	(1,148)	717
Balance at end of period	$ 32,511	$ 33,659

Goodwill and Other Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 94,028	$ 66,249
Accumulated Amortization	(63,020)	(33,011)
Net Carrying Value	31,008	33,238
Indefinite-lived intangible assets	20,479	11,154
Total intangible assets, net	$ 51,487	$ 44,392
Developed technologies
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Life (in years)	6 years	6 years
Gross Carrying Value	$ 12,692	$ 13,076
Accumulated Amortization	(10,878)	(9,198)
Net Carrying Value	$ 1,814	$ 3,878
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Life (in years)	10 years	10 years
Gross Carrying Value	$ 17,823	$ 18,352
Accumulated Amortization	(9,597)	(8,040)
Net Carrying Value	$ 8,226	$ 10,312
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Life (in years)	8 years 6 months	8 years 4 months 24 days
Gross Carrying Value	$ 12,306	$ 12,460
Accumulated Amortization	(8,703)	(7,413)
Net Carrying Value	$ 3,603	$ 5,047
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Life (in years)	3 years 3 months 18 days	3 years 7 months 6 days
Gross Carrying Value	$ 47,818	$ 19,375
Accumulated Amortization	(31,051)	(6,570)
Net Carrying Value	$ 16,767	$ 12,805
Other
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Life (in years)	2 years 6 months	2 years 4 months 24 days
Gross Carrying Value	$ 3,389	$ 2,986
Accumulated Amortization	(2,791)	(1,790)
Net Carrying Value	$ 598	$ 1,196

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 18,000,000.0	$ 9,700,000
Impairment loss on intangible assets	1,400,000	0
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 12,900,000	$ 4,100,000

Goodwill and Other Intangible Assets - Expected Amortization Expense of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
2021	$ 13,026
2022	7,390
2023	4,383
2024	3,937
2025	2,272
Net Carrying Value	$ 31,008	$ 33,238

Fair Value Measurement of Assets and Liabilities - Financial Instruments Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2020	May 12, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of embedded derivative	$ 4,900	$ 4,600
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of cash equivalents	126		$ 126
Fair value of embedded derivative	4,898
Recurring \| Interest make-whole provision
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of embedded derivative	4,898
Recurring \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of cash equivalents	126		126
Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of cash equivalents	126		126
Recurring \| Level 1 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of cash equivalents	126		$ 126
Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of embedded derivative	4,898
Recurring \| Level 3 \| Interest make-whole provision
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of embedded derivative	$ 4,898

Fair Value Measurement of Assets and Liabilities - Binomial Lattice Model and Assumptions (Details) - Level 3 - Interest make-whole payment	Jun. 30, 2020	May 12, 2020 $ / shares	Dec. 31, 2020 $ / shares
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.60	0.50
Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock price		$ 10.62	$ 15.47
Credit spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.1497	0.1925
Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Term	4 years 4 months 2 days	4 years 11 months 19 days
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0
Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.0034	0.0030

Fair Value Measurement of Assets and Liabilities - Activity in Level 3 Liabilities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)
Level 3 Liabilities
Beginning balance	$ 0
Additions	4,582
Conversions	(281)
Change in fair value	597
Ending balance	$ 4,898

Fair Value Measurement of Assets and Liabilities - Other Financial Instruments (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	May 12, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of embedded derivative	$ 4.9	$ 4.9	$ 4.6
Derivative liability extinguished upon debt conversion		0.3
Loss on change in fair value of embedded derivative		0.6
2025 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value of converted amount	$ 13.5	$ 13.5

Debt - Term Loan (Details) - USD ($) $ in Thousands						12 Months Ended
Debt - Term Loan (Details) - USD ($) $ in Thousands	May 12, 2020	Mar. 31, 2020	Mar. 06, 2020	Aug. 09, 2019	Aug. 23, 2017	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Payments repurchase of preferred stock						$ 2,354	$ 0
Series E preferred shares
Debt Instrument [Line Items]
Number of shares sold			25,000	10,000
Stock repurchased (in shares)	2,330
Payments repurchase of preferred stock	$ 2,400
South Ocean Funding LLC \| Series E preferred shares
Debt Instrument [Line Items]
Number of shares sold		2,330
Secured debt \| Term loan
Debt Instrument [Line Items]
Debt aggregate face amount					$ 48,000
Proceeds from term loans					46,900
Proceeds from issuance of debt, portion funded in cash					35,000
Debt issuance costs					500
Debt discount on term loan					$ 4,000
Repayment of outstanding principal	47,500
Repayment of accrued interest	500
Prepayment fee	$ 1,400
Interest rate base minimum (percent)					1.00%
Effective interest rate						15.19%
Secured debt \| Term loan \| LIBOR
Debt Instrument [Line Items]
Applicable margin on interest rate (percent)					7.625%
Convertible debt \| Inseego Notes
Debt Instrument [Line Items]
Proceeds from issuance of debt, portion funded in repurchase and cancellation of debt					$ 11,900
Extinguishment of debt					$ 14,900

Debt - Components (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	May 12, 2020	Dec. 31, 2019	Aug. 23, 2017
Debt Instrument [Line Items]
Fair value of embedded derivative	$ 4,900		$ 4,600
Term loan \| Secured debt
Debt Instrument [Line Items]
Principal amount				$ 47,500
Unamortized debt discount					$ (4,000)
Unamortized debt discount and debt issuance costs				(962)
Net carrying amount				46,538
2025 Notes \| Convertible debt
Debt Instrument [Line Items]
Principal amount	166,898
Fair value of embedded derivative	4,898
Unamortized debt discount	(3,703)
Unamortized issuance costs	(2,946)
Net carrying amount	$ 165,147
2022 Notes \| Convertible debt
Debt Instrument [Line Items]
Principal amount		$ 2	$ 45,000	105,125
Unamortized debt discount and debt issuance costs				(3,791)
Net carrying amount				$ 101,334

Debt - Interest Expense (Details) - USD ($) $ in Thousands	12 Months Ended
Debt - Interest Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Term loan \| Secured debt
Debt Instrument [Line Items]
Contractual interest expense	$ 1,667	$ 4,789
Amortization of debt discount	859	1,331
Amortization of debt issuance costs	103	161
Total interest expense	2,629	6,281
2025 Notes \| Convertible debt
Debt Instrument [Line Items]
Contractual interest expense	3,434
Amortization of debt discount	552
Amortization of debt issuance costs	439
Total interest expense	4,425
2022 Notes \| Convertible debt
Debt Instrument [Line Items]
Contractual interest expense	768	5,782
Amortization of debt discount	1,952	7,821
Amortization of debt issuance costs	111	459
Total interest expense	$ 2,831	$ 14,062

Debt - Convertible Notes (Details)			1 Months Ended	2 Months Ended	3 Months Ended		12 Months Ended
Debt - Convertible Notes (Details)	Jul. 22, 2020 USD ($)	May 12, 2020 USD ($)	Feb. 29, 2020 USD ($) $ / shares shares	Mar. 01, 2021 USD ($) shares	Dec. 31, 2020 USD ($) $ / shares	Mar. 31, 2020 USD ($) shares	Dec. 31, 2020 USD ($) trading_day $ / shares shares	Dec. 31, 2019 USD ($)	Jun. 30, 2020 USD ($)	Jan. 09, 2017 USD ($)	Jun. 10, 2015 USD ($)
Debt Instrument [Line Items]
Proceeds from completed registered offering							$ 100,000,000	$ 0
Cash paid in exchange transaction		$ 32,000,000.0					32,062,000	0
Loss on debt conversion and extinguishment							76,354,000	0
2025 Notes
Debt Instrument [Line Items]
Loss on debt conversion and extinguishment							1,200,000
Debt conversion amount							$ 13,500,000
Conversion (shares) \| shares							1,177,156
Shares in satisfaction of make-whole payment (shares) \| shares							108,572
Value of converted amount					$ 13,500,000		$ 13,500,000
2025 Notes \| Subsequent event
Debt Instrument [Line Items]
Debt conversion amount				$ 5,000,000.0
Conversion (shares) \| shares				428,669
Shares in satisfaction of make-whole payment (shares) \| shares				32,221
2022 Notes
Debt Instrument [Line Items]
Loss on debt conversion and extinguishment		67,200,000
Convertible debt \| 2025 Notes
Debt Instrument [Line Items]
Proceeds from completed registered offering		100,000,000.0
Principal amount					$ 166,898,000		$ 166,898,000
Debt issued in exchange transaction		80,400,000
Stated interest rate of debt issued					3.25%		3.25%
Principal amount per note					$ 1,000		$ 1,000
Conversion ratio							79.2896
Conversion price ($ per share) \| $ / shares					$ 12.61		$ 12.61
Threshold percentage of stock price trigger							130.00%
Threshold of trading days \| trading_day							20
Threshold of consecutive trading days \| trading_day							30
Aggregate percentage of holders to declare notes due and payable in default event							25.00%
Percentage of principal and accrued interest that may be called in default event							100.00%
Percentage of principal and accrued interest that may be called in event of bankruptcy, insolvency or reorganization							100.00%
Stock price trigger (in dollars per share) \| $ / shares							$ 10.51
Interest make-whole payment discount rate					1.00%		1.00%
Notes held by related parties					$ 80,400,000		$ 80,400,000
Effective interest rate					4.10%		4.10%
Convertible debt \| 2022 Notes
Debt Instrument [Line Items]
Principal amount		45,000,000.0						$ 105,125,000	$ 2,000
Estimated fair value of convertible debt		$ 112,400,000
Debt conversion amount	$ 2,000					$ 59,900,000
Conversion (shares) \| shares						13,688,876
Effective interest rate					12.89%		12.89%
Debt aggregate face amount										$ 119,800,000
Convertible debt \| Novatel Wireless Notes
Debt Instrument [Line Items]
Debt conversion amount			$ 250,000
Conversion (shares) \| shares			50,000
Stated interest rate of debt issued											5.50%
Debt issuance costs											$ 3,900,000
Conversion price ($ per share) \| $ / shares			$ 5.00
Debt aggregate face amount											$ 120,000,000.0
Convertible debt \| Privately negotiated exchange agreements
Debt Instrument [Line Items]
Loss on debt conversion and extinguishment						$ 7,900,000
Conversion (shares) \| shares						942,706
Value of converted amount						$ 7,900,000

Income Taxes - Loss before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Domestic	$ (109,837)	$ (39,187)
Foreign	(601)	(387)
Loss before income taxes	$ (110,438)	$ (39,574)

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Current:
Federal	$ 0	$ (49)
State	(4)	35
Foreign	93	1,148
Total current	89	1,134
Deferred:
Federal	12	12
State	0	0
Foreign	647	(610)
Total deferred	659	(598)
Provision for income taxes	$ 748	$ 536

Income Taxes - Net Deferred Tax Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Accrued expenses	$ 1,940	$ 647
Provision for excess and obsolete inventory	2,016	2,003
Convertible debt	13,367	0
Interest expense limitation	7,798	5,562
Net operating loss and tax credit carryforwards	108,340	95,258
Share-based compensation	1,911	1,226
Right-of-use-asset	2,059	650
Unrecognized tax benefits	1,567	1,288
Deferred tax assets	138,998	106,634
Deferred tax liabilities:
Operating lease liability	(2,059)	(650)
Acquired intangible assets	(2,155)	(3,623)
Convertible debt	0	(866)
Depreciation and amortization	(5,545)	(1,742)
Unrealized foreign currency gains	(375)	0
Deferred tax liabilities	(10,134)	(6,881)
Valuation allowance	(133,369)	(103,702)
Net deferred tax liabilities	$ (4,505)	$ (3,949)

Income Taxes - Provision for Income Taxes Reconciliation to Statutory Federal Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal tax benefit, at statutory rate	$ (23,192)	$ (8,311)
State benefit, net of federal benefit	(1,285)	27
Foreign tax rate difference	(140)	476
Valuation allowance against future tax benefits	26,410	9,168
Loss on conversion of debt	2,015	0
Research and development credits	(2,355)	(1,456)
Share-based compensation	(1,134)	341
Other, including true-up of prior year provisions	429	291
Provision for income taxes	$ 748	$ 536

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
Income Taxes - Narrative (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Operating Loss Carryforwards [Line Items]
Valuation allowances recognized in the current year	$ 26,400,000	$ 9,200,000
Employer payroll taxes deferred, CARES Act	1,400,000
Income tax benefit recognized related to uncertain tax positions		0
Interest expense related to uncertain tax positions	0	0
Liability related to unrecognized tax benefits	0	$ 0
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	429,300,000
Operating loss carryforwards, not subject to expiration	81,500,000
Research and development tax credit carryforwards	12,800,000
California Franchise Tax Board
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	55,000,000.0
Research and development tax credit carryforwards	14,000,000.0
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 46,700,000

Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Unrecognized Tax Benefits
Beginning Balance	$ 37,835	$ 36,906
Increases related to current and prior year tax positions	1,796	929
Ending Balance	$ 39,631	$ 37,835

Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended	12 Months Ended
	Mar. 06, 2020	Aug. 09, 2019	Mar. 28, 2019	Aug. 06, 2018	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jan. 22, 2018
Class of Stock [Line Items]
Number of additional shares from warrants (in shares)					1,255,129		1,255,129
Proceeds from the exercise of warrants					$ 6,900	$ 1,861	$ 17,542
Preferred stock, shares authorized					2,000,000	2,000,000	2,000,000
Preferred stock, par value (in dollars per share)					$ 0.001	$ 0.001	$ 0.001
Number of rights issued per common stock (in shares)								1
Preferred stock issued during the period						$ 25,000	$ 10,000
Dividends accrued					$ 400	$ 2,900	$ 400
2018 Warrants
Class of Stock [Line Items]
Number of shares issued (in shares)				12,062,000
Number of additional shares from warrants (in shares)				4,221,700
Proceeds from sale of stock				$ 19,700
Exercise price per share (in dollars per share)			$ 2.52	$ 2.52
Proceeds from the exercise of warrants			$ 10,600
2019 Warrants
Class of Stock [Line Items]
Number of additional shares from warrants (in shares)			2,500,000
Exercise price per share (in dollars per share)			$ 7.00
Series D Preferred Stock
Class of Stock [Line Items]
Exercise price per share (in dollars per share)								$ 10.00
Preferred stock, shares authorized						150,000
Preferred stock, par value (in dollars per share)								$ 0.001
Number of preferred shares issued from exercise of right (in shares)								0.001
Series E preferred shares
Class of Stock [Line Items]
Number of shares issued (in shares)	25,000
Preferred stock, shares authorized					10,000	39,500	10,000
Preferred stock, par value (in dollars per share)	$ 0.001				$ 0.001	$ 0.001	$ 0.001
Purchase price (in dollars per share)	$ 1,000
Preferred stock issued during the period	$ 25,000	$ 10,000
Dividend rate		9.00%
Redemption price		110.00%
Liquidation preference per share (in dollars per share)		$ 1,000			$ 1,000	$ 1,000	$ 1,000
Number of shares sold	25,000	10,000

Stockholders' Equity - Common Shares Reserved for Future Issuance (Details) - shares	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	30,517,721	56,042,995
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	8,479,979	9,044,304
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	417,105	400,315
Convertible Notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	15,879,948	40,649,225
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance or purchase (in shares)	391,201	622,476
Common stock warrants outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	2,500,000	2,838,454
2018 Omnibus Incentive Compensation Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance or purchase (in shares)	2,849,488	2,488,221

Share-based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued upon the exercise of stock options	1,357,620	1,489,067
Share-based compensation expense	$ 10,419	$ 7,302
Shares issued under the ESPP	231,275	203,061
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period of stock options granted	10 years
Weighted-average fair value of stock option awards granted (per share)	$ 7.11	$ 3.56
Intrinsic value of stock options exercised during period	$ 11,700	$ 5,600
Unrecognized share-based compensation expense related to non-vested stock options	$ 12,300
Expected recognition period	2 years 6 months
Share-based compensation expense	$ 5,800	3,500
Stock Options \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Stock Options \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected recognition period	2 years 2 months 12 days
Share-based compensation expense	$ 4,100	$ 3,500
Weighted-average grant-date fair value of RSUs granted (per share)	$ 10.52	$ 5.07
Total vest date fair value of RSUs vested	$ 5,100	$ 4,000
Unrecognized share-based compensation expense related to non-vested RSUs	$ 1,800
Restricted Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Restricted Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under the plan	5,324,000
Share-based compensation expense	$ 600	$ 300
Percentage of lower limit value of common stock	85.00%
Purchase period duration	6 months
Maximum limit of payroll deductions (percent)	10.00%
2018 Omnibus Incentive Compensation Plan \| Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under the plan	8,897,084

Share-based Compensation - Share-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 10,419	$ 7,302
Cost of revenues
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	1,583	1,133
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	2,823	1,548
Sales and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	2,346	1,669
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 3,667	$ 2,952

Share-based Compensation - Weighted-Average Fair Value Assumptions (Details) - Stock Options	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0.00%	0.00%
Risk-free interest rate	0.90%	1.80%
Volatility rate	95.00%	81.00%
Expected term (in years)	5 years 9 months 18 days	5 years 9 months 18 days

Share-based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stock Options Outstanding
Outstanding — beginning of period	9,044,304
Granted	1,526,000
Exercised	(1,357,620)	(1,489,067)
Canceled	(732,705)
Outstanding — end of period	8,479,979	9,044,304
Vested and Expected to Vest — December 31, 2020	7,667,800
Exercisable — December 31, 2020	4,293,975
Weighted-Average Exercise Price Per Option
Outstanding — beginning of period	$ 2.91
Granted	9.41
Exercised	3.06
Canceled	3.60
Outstanding — end of period	3.99	$ 2.91
Vested and Expected to Vest — December 31, 2020	3.71
Exercisable — December 31, 2020	$ 2.10
Weighted-Average Remaining Contractual Term (Years), Options Outstanding	7 years 5 months 19 days
Weighted-Average Remaining Contractual Term (Years), Options Vested and Expected to Vest	7 years 4 months 2 days
Weighted-Average Remaining Contractual Term (Years), Options Exercisable	6 years 4 months 28 days
Aggregate Intrinsic Value, Options Outstanding	$ 97,315
Aggregate Intrinsic Value, Options Vested and Expected to Vest	90,150
Aggregate Intrinsic Value, Options Exercisable	$ 57,398

Share-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Restricted Stock Units
Non-vested — beginning of period	400,315
Granted	570,368
Vested	(548,160)
Forfeited	(5,418)
Non-vested — end of period	417,105	400,315
Weighted-Average Grant-Date Fair Value
Non-vested — beginning of period	$ 3.95
Granted	10.52	$ 5.07
Vested	7.28
Forfeited	4.06
Non-vested — end of period	$ 8.68	$ 3.95

Earnings per Share - Narrative (Details)	12 Months Ended
Earnings per Share - Narrative (Details)	Dec. 31, 2020 shares
Earnings Per Share [Abstract]
Anti-dilutive shares excluded from EPS calculation	26,180,766

Earnings per Share - Calculation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Net loss attributable to common stockholders	$ (13,593)	$ (6,271)	$ (75,665)	$ (18,590)	$ (13,285)	$ (8,937)	$ (10,779)	$ (7,485)	$ (114,119)	$ (40,486)
Weighted-average common shares outstanding, basic and diluted (in shares)									96,111,547	78,322,496
Basic and diluted net loss per share (in dollars per share)	$ (0.14)	$ (0.06)	$ (0.78)	$ (0.20)	$ (0.17)	$ (0.11)	$ (0.14)	$ (0.10)	$ (1.19)	$ (0.52)

Commitments and Contingencies (Details) - USD ($) $ in Millions			1 Months Ended
	Jul. 24, 2020	Jul. 26, 2018	Mar. 31, 2017
Former Stockholder Of RER
Loss Contingencies [Line Items]
Amount award to other party		$ 1.0
Stock issued during period, litigation settlement (in shares)	89,928	500,000
Additional amount awarded to other party, within 12 months		$ 1.0
Additional amount awarded to other party, within 24 months		$ 1.0
RER
Loss Contingencies [Line Items]
Stock issued during period, shares, acquisitions (in shares)			973,333

Leases - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Leases - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Right-of-use assets, net	$ 9,092	$ 2,657
Operating lease liabilities	$ 9,904
Weighted-average remaining lease term	5 years 9 months 18 days
Weighted-average discount rate	9.10%
Cash paid for operating leases	$ 1,900	2,200
Operating lease costs	$ 2,200	$ 2,400
Operating lease liabilities, current, balance sheet line item	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
Operating lease liabilities, noncurrent, balance sheet line item	Other long-term liabilities	Other long-term liabilities

Leases - Future Minimum Payments Under Operating Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2021	$ 2,460
2022	2,225
2023	1,916
2024	1,787
2025	1,630
Thereafter	2,807
Total minimum operating lease payments	12,825
Less: amounts representing interest	(2,921)
Present value of net minimum operating lease payments	9,904
Less: current portion	(1,619)	$ (1,101)
Long-term portion of operating lease obligations	$ 8,285

Geographic Information and Concentrations of Risk - Geographic Concentration of Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Geographic concentration of assets
Assets	$ 227,394	$ 161,373
United States and Canada
Geographic concentration of assets
Assets	148,485	81,769
South Africa
Geographic concentration of assets
Assets	48,211	53,610
Other
Geographic concentration of assets
Assets	$ 30,698	$ 25,994

Geographic Information and Concentrations of Risk - Geographic Concentration of Net Revenues (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net revenue by geographic region
Net revenues	$ 86,063	$ 90,240	$ 80,689	$ 56,840	$ 52,333	$ 62,716	$ 55,891	$ 48,556	$ 313,832	$ 219,496
United States and Canada
Net revenue by geographic region
Net revenues									260,009	158,756
South Africa
Net revenue by geographic region
Net revenues									28,208	35,001
Other
Net revenue by geographic region
Net revenues									$ 25,615	$ 25,739

Geographic Information and Concentrations of Risk - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net foreign currency transaction losses	$ (0.7)	$ (0.3)
Net Revenues \| Customer Concentration \| Customer One
Segment Reporting Information [Line Items]
Concentration percentage	54.50%	52.50%
Accounts Receivable \| Customer Concentration \| Customer One
Segment Reporting Information [Line Items]
Concentration percentage	33.30%	25.00%
Accounts Receivable \| Customer Concentration \| Customer Two
Segment Reporting Information [Line Items]
Concentration percentage	17.20%	11.20%

Retirement Savings Plan (Details) - USD ($) $ in Millions	12 Months Ended
Retirement Savings Plan (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Retirement Benefits [Abstract]
Percentage of employees contribution matched by employer	50.00%
Percentage of employees gross pay eligible for employer match	6.00%
Employer matching contributions	$ 0.7	$ 0.4

Quarterly Financial Information (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]
Net revenues	$ 86,063	$ 90,240	$ 80,689	$ 56,840	$ 52,333	$ 62,716	$ 55,891	$ 48,556	$ 313,832	$ 219,496
Gross profit	26,447	25,170	22,000	17,227	15,031	18,625	15,555	14,760	90,843	63,971
Net loss attributable to common stockholders	$ (13,593)	$ (6,271)	$ (75,665)	$ (18,590)	$ (13,285)	$ (8,937)	$ (10,779)	$ (7,485)	$ (114,119)	$ (40,486)
Net loss per share, basic and diluted (in dollars per share)	$ (0.14)	$ (0.06)	$ (0.78)	$ (0.20)	$ (0.17)	$ (0.11)	$ (0.14)	$ (0.10)	$ (1.19)	$ (0.52)

Subsequent Events (Details) - Subsequent event $ / shares in Units, R in Millions, $ in Millions	1 Months Ended
	Jan. 31, 2021 USD ($) $ / shares shares	Feb. 24, 2021 USD ($)	Feb. 24, 2021 ZAR (R)	Jan. 25, 2021 USD ($)
Subsequent Event [Line Items]
Number of shares issued (in shares) \| shares	1,516,073
Purchase price (in dollars per share) \| $ / shares	$ 20.11
Proceeds from sale of stock	$ 29.6
Canaccord Genuity LLC
Subsequent Event [Line Items]
Equity Distribution Agreement, maximum aggregate amount authorized for offer or sale				$ 40.0
Convergence
Subsequent Event [Line Items]
Share Purchase Agreement, transaction price per agreement		$ 36.2	R 528.9